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Chronic obstructive pulmonary disease (COPD) is currently the third leading cause of death 
worldwide according to the World Health Organization (WHO) and is expected to become an 
even more serious problem in upcoming decades. Cigarette smoking is the major risk factor 
for COPD and lung cancer. Although COPD is one of the most important chronic lung diseas-
es, our knowledge about the underlying molecular framework is only fragmentary. 
Hence, this study introduces D. melanogaster as a novel model for basic COPD research that 
allows testing hypotheses experimentally. Various cigarette smoke exposure (CSE) models 
using different exposure regimes were implemented in the course of this study and the in vivo 
impact of CSE was analyzed using 3rd instar larvae. The airways showed a strong structural 
modification and an activation of JAK-STAT signaling in the epithelial cells of CS treated 
animals. Moreover, expression of the ligands of this pathway belonging to the upd family was 
induced upon CSE. Both, upd2 and upd3 and the receptor dome of the JAK-STAT pathway, 
were strongly expressed at the posterior end of the dorsal branches, indicative for an autocrine 
signaling system. The exact function and role of these ligands, especially in the tracheal sys-
tem of D. melanogaster are still poorly understood. In silico analysis of the structures of upd3 
with IL-6 of mouse, implied an ancestral relationship between both cytokines. Moreover, an 
ectopic expression of these components of the JAK-STAT pathway in the airway epithelium 
of Drosophila resulted into epithelial barrier disruption in form of meta- and hyperplasia. To 
unravel potential upstream regulators for the expression of these upd ligands, different flies 
deficient in expression of either dFoxO or relish were used. Both are essential for the two ma-
jor arms of the fly's airway epithelial immune system and thus were exposed to smoke. Espe-
cially, in dFoxO deficient flies, induction of upd2 and upd3 transcripts were significantly re-
duced. Electrophoretic mobility shift assays underline the potential role of dFoxO in directly 
regulating upd2 and upd3 expression. Furthermore, cigarette smoke results in structural re-
modeling including thickening of the epithelial layer, in parallel with activation of JAK/STAT 
signaling that may be triggered by dFoxO activation.  
Beside this CSE based model for COPD research, destruction of the terminal airway structure 





COPD ist derzeit nach Angaben der Weltgesundheitsorganisation (WHO) die dritthäufigste 
Todesursache weltweit und die Zahl der Rauchertoten nimmt in den kommenden Jahren 
immer mehr zu. Das Rauchen von Zigaretten oder das Passiv-Rauchen ist der größte 
Risikofaktor für COPD und Lungenkrebs. Obwohl COPD eine der bedeutendsten chronischen 
Lungenerkrankungen ist, ist unser Wissen über die zugrunde liegenden molekularen 
Signalwege und Gene derzeit nur bruchstückhaft. 
Die vorliegende Arbeit hatte daher zum Ziel, D. melanogaster als ein neues Modell für die 
Grundlagenforschung der COPD einzuführen, um Hypothesen schnell testen zu können. Das 
Drosophila-Modell hat drei wesentliche Vorteile, zum einen, eine Fokussierung auf das 
Atemwegsepithel ohne Einflüsse einer adaptiven Immunantwort, die enorme zeitliche 
Einsparung der Experimentendauer und die recht einfache Isolierung der Tracheen. Es wurde 
dabei die Relevanz von Zigarettenrauch im Atemwegsepithelium von Drosophila untersucht 
und eine epitheliale Immunreaktion gezeigt. Die Applikation von Zigarettenrauch in 
Drosophila hatte eine Beeinträchtigung der epithelialen Barriere zur Folge und eine 
Aktivierung des JAK-STAT-Signalwegs konnte gezeigt werden. Außerdem erfolgte eine 
Zigarettenrauch-induzierte Expression der Liganden Upd2 und Upd3 sowie des Rezeptors 
Domeless, welche die Hauptkomponenten des JAK-STAT- Signalwegs sind. Die Induktion 
des JAK-STAT-Signalwegs erfolgte spezifisch an den doralen Verzweigungen der primären 
Tracheen, was für ein autokrines Signalisierungssystem spricht. Die genaue Funktion und 
Rolle dieser Liganden sind vor allem in den Tracheen von D. melanogaster noch weitgehend 
unverstanden. Daher wurden sowohl strukturelle Vergleiche von upd3 mit der bekannten 
Kristallstruktur von IL-6 als auch eine funktionelle Überexpression dieser Liganden in den 
Tracheen vorgenommen, um diese näher charakterisieren zu können. Eine ektopische 
Überexpression dieser Komponenten im Atemwegsepithel von Drosophila führte zu einer 
Störung der Epithelbarriere in Form einer Meta- und Hyperplasie.  
Um mögliche Regulatorgene für die Expression dieser Upd-Liganden zu entschlüsseln, 
wurden Mutanten, defizient in den Transkriptionsfaktoren dFoxO und Relish verwendet und 
ebenfalls mit Zigarettenrauch behandelt. Insbesondere in dFoxO defizienten Fliegen war die 
Induktion der Upd2 und Upd3- Transkripte deutlich reduziert. Electrophoretic Mobility Shift 
Assays unterstreichen die potentielle Rolle des Transkriptionsfaktors dFoxo in seiner direkten 
Regulation von Upd2 und Upd3. Eine spezifische Bindung von dFoxO mit entsprechenden 
intakten potentiellen Bindesequenzen konnte gezeigt werden. Für die DNA-Bindungsanalysen 
wurde dFoxO in Form eines HIS-Fusionsproteins in E. coli überexprimiert und aufgereinigt.  
Zusammenfassung 
 III 
Weiterhin konnte gezeigt werden, dass Zigarettenrauch zur Atemwegsmodelierung in Form 
einer verdickten Epithelschicht führt, das mit einer parallelen Aktivierung des JAK-STAT-
Signalweges einhergeht, welcher vermutlich dFoxO abhängig ist.  
Neben dem Zigarettenrauch-Modell für die COPD-Forschung, wurde ein alternatives Modell 
entwickelt, das sich der Bedeutung des cAMP-Signalings im Atemwegsepithel widmet.  
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1. Introduction  
1.1 Chronic obstructive pulmonary disease (COPD) 
1.1.1 Pathogenesis and pathophysiology of COPD 
Respiratory diseases, like chronic obstructive pulmonary disease (COPD) or asthma, affect a 
very large proportion of people in the world in terms of morbidity and mortality (Ferkol & 
Schraufnagel, 2014). According to the World Health Organization (WHO) almost 329 million 
people (approximately 4.77% of the world's population) suffer from COPD. The impact of 
this disease is almost equally distributed between males (4.85%) and females (4.69%) 
(Pauwels & Rabe, 2004; Vos et al, 2012).  
COPD, also known as chronic obstructive lung disease (COLD), is a slow progressive and 
irreversible lung disease characterized by the functional abnormality of airway obstruction, 
which makes breathing difficult (Barnes et al, 2009). The term "progressive" means the dis-
ease typically worsens over time. At first, COPD may cause no or only mild symptoms, as the 
disease progresses some common symptoms occur, such as shortness of breath (dyspnea), 
wheezing and chest tightness and an ongoing cough along with mucus hyper secretion 
(Agusti, 2005). COPD worsens over the time and breathing requires much more energy and 
its getting difficult for COPD patients to deal with routine activities. This might lead to fa-
tigue, weight and muscle loss. COPD is largely associated with exposure to cigarette smoke 
as the most important risk factor but also long-term exposure to second-hand smoke like air 
pollutants, dust or workplace fumes and even biomass exposure such as wood smoke can con-
tribute to COPD development (van der Vaart et al, 2004) (Salvi & Barnes, 2009). Tobacco 
smoke irritates the airways causing an inflammatory response and destroys the stretchy fibers 
in the lungs, resulting in a breakdown of the lung tissue known as emphysema (Hecht, 2003). 
Smoking damages mainly two parts of the lung: the airways and the small air sacs called al-
veoli (Eisner et al, 2005) (Figure 1-1 A). The airway epithelium constitutes the first barrier of 
defense against the toxic effects of cigarette smoke. It is a pseudo-stratisfied barrier that con-
sists of multiple cell types such as goblet cells, clara and ciliated cells, which are generated by 
the basal cells (Figure 1-1 B). The bronchial tubes are lined with these tiny hair-like cilia 
cells which are important for secreting harmful substances out of the lungs.  
Between the cilia cells there is another cell type organized called goblet cells, which are re-
sponsible for the production of mucus.  
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Cigarette smoke irritates the lining of the bronchial tubes causing them to swell and increase 
mucus production extensively. Smoking also slows down the movement of the ciliated cells 
causing some of the smoke components and mucus to remain and accumulate in the lungs. A 
selected summary of hazardous chemical compounds found in cigarette smoke and their ef-
fects on human airways are listed in Table 1-1. 
 
Table 1-1: Selected components of cigarette smoke and their potential role in lung injury 
Component Effect on airways  
Cadmium Oxidative injury, promotion of emphysema, tight junction disruption 
Formaldehyde Cilia toxic; irritant 
Nitrogen oxides Oxidant activity 
Hydrogen cyanide Oxidative metabolism of cells affected 
Acetaldehyde  Probable human carcinogen; irritant to respiratory tract 
1,3-Butadiene Known human carcinogen, irritant to upper respiratory tract 
Acrolein Cilia toxic; impairs lung defenses, known DNA mutagen, irritant to 
skin and nasal passages 
N-Nitrosamines Known human carcinogen, increases risk for lung cancer may cause 
reproductive damage 
 
Most of the ciliated cells are recovering and trying to release these pollutants together with the 
mucus out of the lungs. The human body tries to expel this material by repeated coughing, 
also known as smoker's cough. Chronic bronchitis develops over time, as this detoxification 
process overwhelms the cilia cells and the airways become blocked with mucus thus breathing 
becomes difficult. Moreover, lungs become more susceptible towards airborne pathogens like 
viruses and bacteria. The alveoli gets overdistended and are finally damaged in their elastic 
fibers which makes it harder for oxygen and carbon dioxide to exchange with the blood, lead-
ing to the development of emphysema. Chronic bronchitis and emphysema are collectively 
called as COPD. The normal remodeling process of wound-healing is completely damaged in 
the lung tissue of smokers suffering from COPD. The obstruction of the airways is related to 
an inflammatory process that leads into thickening of the airway wall which in turn narrows 
the airways by depositing connective tissue (Figure 1-1 A).  
Cigarette smoke also disrupts the tight and adherens junctions that form the epithelial barrier 
(Hulbert et al, 1981; Jones et al, 1980). This leads into destabilization of the epithelial integri-





Figure 1-1: The human respiratory system and its various different cell types. (A) The lungs are a pair of 
spongy, air-filled organs located on either side of the chest (thorax). The trachea, also called windpipe, conducts 
inhaled air into the lungs through its tubular branches, called bronchi. The bronchi then divide into smaller 
branches (bronchioles), finally becoming microscopic. The bronchioles eventually end in clusters of microscopic 
air sacs called alveoli. In the alveoli, oxygen from the air is absorbed into the blood (source: www.webmd.com). 
The alveoli are lined by a delicate layer of simple squamous epithelia. Outside the epithelial lining is a delicate 
connective tissue containing numerous elastic fibers and a close network of blood capillaries, forming a common 
wall to adjacent alveoli. The epithelial membrane of smokers with and without COPD is characterized by a 
thickening of the airway wall, which leads into a breakdown of elastin and collagen proteins and finally into 
destruction of the airways. (B) The bronchial tubes are composed mainly of five cell types; clara (secretory) 
cells, tiny hair-like cells called cilia cells, pulmonary neuroendocrine (NE) cells, basal cells and goblet (mucous) 
cells. 
 
The abnormal remodeling of the airway tissue is associated with deregulation of cytokines, 
chemokines and other growth factors. Basal cells hyperplasia and squamous metaplasia are 
the earliest airway epithelial lesions associated with smoking-induced carcinogenesis 
(Shaykhiev et al, 2013). 
Smoking-induced oxidative stress due to high concentrations of free radicals leads into the 
generation of additional reactive oxygen species (ROS) within the airways. Naturally, ROS 
can also be produced intracellularly from several sources, such as mitochondrial respiration, 
which is the most important source of free radicals. Nevertheless, in smokers and COPD pa-
tients higher ROS levels are present compared to healthy persons.  
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A consequence of this higher oxidative stress is the enhanced expression of inflammatory 
mediators through redox-sensitive transcription factors like nuclear factor-kappa B (NF-ҡB). 
On the other hand, controlling transcription factors of cellular resistance to oxidants, like Nrf2 
(the nuclear factor erythroid2-related factor 2), are getting activated (Ma, 2013). 
 
1.1.2 Physiological role of second messengers in COPD pathogenesis   
Cyclic adenosine 3′,5′-monophosphate (cAMP) was the first intracellular signaling molecule 
to be identified by Earl W Sutherland Jr. and Theodore W. Rall in 1956 (Sutherland & Rall, 
1958). This second messenger modulates a variety of processes in the airways such as produc-
tion and secretion of inflammatory mediators and extracellular matrix, proliferation, differen-
tiation, migration, epithelial cells mucus secretion, wound healing, anion transport and ciliary 
beating (Billington & Hall, 2012; Giembycz & Newton, 2006; Salathe, 2002). cAMP is a crit-
ical key player by regulating the airway tone, being the major pro-relaxant effector in combat-
ing the pathophysiology of airway narrowing and remodeling (Billington & Hall, 2012; 
Billington et al, 2013). Thus, the decrease of cAMP levels in the human lung has a significant 
role in the development of COPD and asthma. 
All cAMP-mediated pathways are most commonly initiated following the binding of specific 
ligands (e.g. hormones, neurotransmitters, growth factors, cytokines, active oxygen, drugs, 
toxins, etc) to G protein-coupled receptors (GPCRs) of the Gs-Protein and Gi-Protein coupled 
signal transduction family (Billington et al, 2013). These G-proteins are linked to an enzyme, 
adenylyl cyclase (AC) that dephosphorylates ATP to form cAMP. The activated Gs subunit 
stimulates, while the Gi subunit inhibits the AC. The resulting increase in intracellular cAMP 
reduces the smooth muscle tone, thus dilating the airways. cAMP then activates other cAMP 
dependent effectors like protein kinase A (PKA) and EPAC by binding to their regulatory 
subunits and allowing them to phosphorylate a wide range of cellular targets leading to 




Figure 1-2: The cAMP signaling pathway. Following the binding of hormones, neurotransmitters and other 
lipids, the GPCR is getting activated and undergoes a conformational change that is transmitted to an attached 
intracellular heterotrimeric G protein complex. The Gs alpha subunit of the stimulated G protein complex ex-
changes GDP for GTP and is released from the complex, binds to and activates then AC. AC in turn, catalyzes 
the conversion of ATP into cAMP. Increased concentrations of the second messenger cAMP lead to the activa-
tion of PKA. The release of PKA phosphorylates a number of other proteins, e.g. cAMP response element bind-
ing (CREB) transcription factors, phospholipase C (PLC), inositol triphosphate receptor and β2 adrenoreceptor 
leading to bronchorelaxation. 
 
Phosphodiesterases (PDE) are enzymes responsible for cAMP degradation. In human airway 
smooth muscle cells (ASM), PDE4 has been found to be the major PDE subtype that is in-
volved in cAMP degradation leading to narrowing of the airways (Nino et al, 2009). Inhibi-
tors of the PDE4 family such as roflumilast and cilomilast have been used in clinical trials or 
have been licensed for use in COPD (Spina, 2008). However, to date little is known about 
how alterations and higher intracellular cAMP levels affect the respiratory system. 
Another important second messenger, responsible for airway remodeling and extensive air-
way narrowing, is cytoplasmic Ca
2+
. In response to signal molecules from other cells, the cell 
surface receptor protein, another G-protein coupled receptor, activates a Gq protein, which in 
turn activates the enzyme phospholipase C (PLC). PLC in turn hydrolyzes phosphatidylinosi-
tol 4, 5-bisphosphate (PIP2) to diacyl glycerol (DAG) and inositol trisphosphate (IP3).  
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DAG remains bound to the membrane and acts as a second messenger that activates protein 
kinase C (PKC). IP3 then diffuses through the cytoplasm to bind to IP3 receptors, particular 
calcium channels in the endoplasmic reticulum (ER), allowing calcium ions to flow from the 
ER into the cytoplasm (Figure 1-3) (Thore et al, 2005). 
 
 
Figure 1-3: Phospholipase C pathway and Ca
2+
 -signaling. Many cell surface receptors, including G protein-
coupled receptors and receptor tyrosine kinases activate the PLC enzyme. PLC hydrolyses PIP2 into two second 
messengers: IP3 and DAG. DAG activates PKC, while IP3 diffuses to the endoplasmic reticulum (ER) and binds 
to the IP3 receptor, which is a Ca
2+
 channel and thereby releases Ca
2+
 from the ER into the cytoplasm. 
 
These secreted calcium ions can further bind to epithelial NADPH oxidase family proteins 
like dual oxidases. Dual oxidases generate ROS by producing H2O2 at the epithelial cell sur-
face. Dual oxidase 1 and 2 are expressed in the airway epithelium of smokers and patients 
with mild/moderate COPD (Nagai et al, 2008). A higher concentration of Ca
2+
- ions leads into 
ASM contraction (Bergner et al, 2006; Jin et al, 2006; Kellner et al, 2008). Moreover, in-




 channel 1, is associated with mucus overproduction 




1.2 Modeling human diseases in Drosophila melanogaster 
1.2.1 Drosophila melanogaster as a model to study smoke related diseases like 
COPD 
Progress in unraveling the role of COPD-susceptibility genes in the recent years revealed that 
biomedical research critically depends on suitable animal models to obtain a fast and adequate 
understanding of involved disease pathways and genes for development and discovery of 
therapeutic drugs. Drosophila is among the limited number of well-established and generally 
accepted model organisms (mice, yeast, C. elegans, zebra fish, rat). It is the oldest model or-
ganism that had been introduced first by Thomas Hunt Morgan and has been applied since 
then to a large number of human diseases (Bier, 2005; Pandey & Nichols, 2011). The fly ge-
nome has been completely sequenced and annotated and nearly 75% of human disease-related 
genes are believed to have a functional homolog in the fly (Adams et al, 2000; Pandey & 
Nichols, 2011). Among the first ones were those focusing on neurodegenerative disorders like 
Parkinson's disease (Feany & Bender, 2000). Chan and Bonini (Chan & Bonini, 2000) suc-
ceeded establishing Drosophila to model Alzheimer, which triggered a great number of fol-
low-up studies leading to new therapeutic ideas. Further, it's not surprising that the fruit fly 
serves as a tremendous tool to study cerebral cavernous malformations (Song et al, 2013), as 
synteny analyses revealed that CCM3/PDCD10 gene shares the same genomic loci from Dro-
sophila to human and the gene structure remains conserved (Kumar et al, 2014). In addition, 
other neuroscience studies have shown Drosophila to perform complex behavioral tasks such 
as learning and memory, sleep and even aggression (Bellen et al, 2010).  
Other disease modeling approaches utilizing Drosophila focused on cardiovascular diseases 
(Wolf et al, 2006), diabetes (Baker & Thummel, 2007) and intestinal diseases (Lee & Lee, 
2014). Recently, the fly has been increasingly used in cancer research.  
The majority of cancers are derived from epithelial cells and misregulation of signaling path-
ways. Highly important was the elucidation of the Ras signal transduction cascade (Olivier et 
al, 1993; Simon et al, 1991). Current research shows the flies potential in understanding hu-
man inflammatory and infectious diseases exposing them to pathogens, e.g. fungi and bacteria 
and inquiring the release of AMPs (anti microbial peptides) in the intestine. Even in kidney- 
related diseases, the fly has shown to be a potential candidate to study kidney stone formation 




However, there is only a slow progress in elucidating Drosophila as a model to study airway 
related diseases such as asthma (Roeder et al, 2009; Roeder et al, 2012; Wagner et al, 2009) 
and not yet for either COPD or lung cancer. One of the reasons is that flies lack an adaptive 
immune system, including IgEs, T-cells and most aspects of interleukin signaling, which is 
thought to be highly relevant for understanding asthma or other lung specific diseases. A new 
approach in Drosophila genetics is the establishment of "humanized" flies carrying transgenic 
arrays of the corresponding human genes, or their variations. This method is successfully ap-
plied in the field of neurodegenerative diseases (Feany & Bender, 2000) and even to explore 
the function of asthma susceptibility genes in the respiratory track of the fly, e.g. ORMDL 
(Kallsen et al, 2015). 
 
1.2.2 Structure of the respiratory system of D. melanogaster  
Most animals possess an oxygen delivery system and the architecture of these branching net-
works is highly conserved throughout the animal kingdom. Respiratory epithelia are charac-
terized as a complex network of branched tubules. In humans, the airway epithelium is a 
pseudo-stratified barrier that consists of multiple cell types whereas the larval trachea of Dro-
sophila is a single-layered epithelium of approximately 1600 cells. It is covered by a central 
lumen that provides the first barrier against invading microorganisms and other environmental 
stimuli. The airway epithelium of the fly consists of approximately 10.000 interconnected 
tubes that transport the oxygen and other gases throughout the body (Affolter et al, 2003; 
Ghabrial et al, 2003). Green et al. has introduced C. elegans as an invertebrate model organ-
ism to study the impact of cigarette smoke to unravel COPD mediated responses (Green et al, 
2009). Compared to the C. elegans model, Drosophila has the major advantage that it pos-
sesses an airway system, which shares similarities to those of vertebrates. Nematodes lack 
both specialized respiratory systems and complex circulatory organs. They must rely on diffu-
sion from the surrounding environment into their tissues for gas exchange (Lopez Hernandez 
et al, 2015; Paget et al, 1987; Van Voorhies & Ward, 2000).  
Although the physiology of airway epithelium of Drosophila larvae is simpler in structure and 
its organization is very delicate, cellular and molecular mechanisms resemble the overall de-
sign of the human lung (Horowitz & Simons, 2008; Roeder et al, 2012).  
The air enters the trachea through specialized openings, so called posterior spiracles and pass-






Figure 1-4: The respiratory system of D. melanogaster. The tracheal system of the larvae (L3) is characterized 
by two pairs of respiratory openings (spiracles). Both primary branches run in parallel through the entire body of 
the larva and split in nearly every segment to the inner and outer secondary branches. These secondary branches 
are finally branched into fine tertiary branches (tracheoles), which are in direct contact to other organs, e.g. gut 
and oenocytes to supply them with oxygen. The trachea was visualized by X-Gal staining (ppk4-Gal4::lacZ-
UAS) with the ppk4-Gal4 driver line to label the entire airway system. 
 
The terminal branches are very fine (< 1μm diameter) and terminal branching is highly varia-
ble and regulated by the oxygen supply. Their pattern is very organized, for instance terminal 
branches do not cross over one another and are regularly spaced. Interestingly, larvae which 
were grown under anoxic conditions, show dramatic increases in terminal branching in con-
trast to larvae grown under high oxygen levels, which have less number of terminal branches. 
The formation of the terminal branches are regulated by the gene DSRF/ blistered, a Drosoph-
ila homolog of the serum response factor. DSRF is specifically expressed in the terminal 
branches (Gervais & Casanova, 2011).  
Liquid clearance of the tracheal system is performed by several epithelial degenerin/ Na
+
 
channels (ENaCs) and their family members, e.g. PPK4 and PPK11 are expressed quite spe-
cifically in the tracheal system (Liu et al, 2003b). They are not only important for clearing and 
replacing liquid by air but also contribute to proper differentiation of the tracheal cells. Most 
of the clinically relevant lung syndromes are caused by the failure of liquid clearance and res-
piratory-tube size control. 
Coracle is an essential component of septate junctions of the epithelial cells, which are neces-




Figure 1-5: Septate junctions of the fly's airway epithelial cells. The larval trachea (L3 instar) was stained 
with α-coracle antibody (red) to highlight the septate junctions. DAPI (blue) was used to stain the nuclei. Scale 
bar: 100 µm. 
 
1.2.3 Respiratory defense mechanisms in D. melanogaster 
D. melanogaster lacks an adaptive immune system, but possesses an innate immune response 
similar to that of humans, employing three major signaling pathways namely the Toll, Im-
mune deficiency (Imd) and Janus Kinase and Signal Transducer and Activator of Transcrip-
tion (JAK/STAT) pathway (Lemaitre & Hoffmann, 2007). This is one of the advantageous 
aspects making D. melanogaster an appropriate in vivo model to study all innate immune re-
lated functions without the interference of the adaptive immune system.  
The innate immune responses play a crucial role for maintaining inflammation and tissue de-
struction in COPD (Schleimer, 2005). In the early stages of the disease, the airways of smok-
ers are bombarded with large quantities of hazardous chemical compounds. Activation of 
phagocytic cells occurs and results in the release of many mediators, which are believed to 
remodel the airways. Finally, the failure of the innate immune defense system as a result of 
inhalation of smoke, is likely to result in increased susceptibility towards infection by patho-
genic and opportunistic organisms. Innate immunity is the oldest host defense mechanism and 
is highly conserved across many species. Almost all major signal transduction pathways are 
also found in Drosophila, performing the same biochemical functions and are arranged in the 
functional order.  
This chapter describes some important genes and pathways of the fly's respiratory system 





Figure 1-6: Respiratory defense mechanisms of D. melanogaster. Septic injury or other stressors (e.g. oxida-
tive stress of CSE) activate several signaling pathways and transcription factors: The JAK-STAT signaling 
pathway is composed of 4 major components: the ligands unpaired 1-3, the receptor domeless (Dome), the JAK 
kinase Hopscotch/Hop and the STAT transcription factor (STAT92E). Activation of IMD and JNK signal trans-
duction is normally initiated by gram-negative bacterial peptidoglycan directly binding to PGRP-LC, to signal to 
IMD. Further IMD regulates the MAPK kinase TAK1 (transforming growth factor β-activated kinase 1), which 
then stimulates IKK-dependent cleavage and activation of the TF relish. IMD-signaling induces AMP release, 
e.g. drosomycin. The FADD-Dredd pathway also activates relish. TAK1 is also another activator of the JNK 
pathway. The transcription factor dFoxO is controlled by JNK and insulin signaling. The dFoxO activity is re-
pressed by insulin signaling. Another transcription factor which has been shown to activate gene expression in 
response to CSE (e.g. GstD) is cap-n-collar. Keap1 (Kelch-like ECH-Associated Protein 1) is its specific re-
pressor. 
 
The Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) pathway is 
very conserved among all species from insects to mammals and plays an important role in 
mediating pro-inflammatory cytokines like interleukin-6 (IL-6) in mammals (Hou et al, 2008; 
Levine & Wernig, 2006). JAK-STAT signaling was first discovered in mammalian systems in 
the transduction of a variety of cytokines and growth factor signals (Darnell, 1997). It is re-
sponsible for regulating immune responses to septic injury and infection by bacterial and viral 
pathogens. However, this pathway is less complex in Drosophila (Brown et al, 2003). In the 
Drosophila genome there are three related IL-6-like cytokines, namely upd (unpaired or out-





They can bind to a gp130-like cytokine receptor called domeless (dome) to regulate the activi-
ty of JAK-STAT signaling (Arbouzova & Zeidler, 2006; Brown et al, 2001; Wright et al, 
2011). The transmembrane receptor domeless then in turn activates the Janus Kinase (JAK) 
hopscotch (hop) (Binari & Perrimon, 1994). Activated hop induces phosphorylation of the 
signal transducer and activator of transcription STAT92E in order to activate transcription of 
genes that are critical to the inflammatory response. Hopscotch, the only single JAK gene of 
Drosophila, is most similar to human JAK2 (27% identity) and STAT92E is most homolo-
gous to human STAT5 (37% identity) (Zeidler et al, 2000).  
Another signaling pathway is the IMD pathway, which shares some similarities with the ver-
tebrate TNF-R (tumor necrosis factor receptor) pathway and is expressed in the fly's airway 
epithelium (Wagner et al, 2008). The pathway consists of eight additional canonical compo-
nents: the PGRP-LC receptor (Choe et al, 2002), an intracellular adaptor protein containing a 
death domain IMD, the mitogen-activated protein 3 kinase (Map3K) TAK1 (Silverman et al, 
2003; Vidal et al, 2001), which phosphorylates and activates the IKK signalosome (IKKβ - 
IRD5 and IKKγ - Kenny homolog) (Kleino & Silverman, 2014) and leads into phosphoryla-
tion and nuclear translocation of relish, the homolog of human NF-kB (Stoven et al, 2000; 
Stoven et al, 2003).  
Upon direct binding of gram-negative bacteria, PGRP-LC recruits the adaptor IMD (Choe et 
al, 2005; Kaneko et al, 2006). IMD interacts with the Drosophila Fas-associated death domain 
ortholog (dFADD) that binds to death related ced-3/nedd2-like caspase (DREDD) (Hu & 
Yang, 2000). Once this caspase is phosphorylated via the IKK signaling complex (Silverman 
et al, 2000), it cleaves relish by removing the C-terminal inhibitor ankyrin-repeat/IҡB-like 
domain, which remains in the cytoplasm. It allows the relish DNA-binding domain (Rel68) to 
translocate from the cytoplasm into the nucleus, where it induces transcription of other target 
genes, e.g. binding to ҡB-motifs of antimicrobial peptide genes (AMPs) (Engstrom et al, 
1993). 
The vital parts of the Toll-pathway with its core components such as the ligand spätzle, the 
receptor toll, the intracellular adaptors myD88 and tube and the kinase pelle, were reported to be 
missing in the tracheal system of D. melanogaster and only the NF-κB homologs dorsal (Dl) 
and dif are present (Wagner et al, 2008).  
Beside these three major signaling pathways, transcription factors play a remarkable role in 
regulating the epithelial immune responses. Of central importance for proper response to oxi-
dative stress is the activation of the transcription factor FoxO (Becker et al, 2010; Greer & 
Brunet, 2005; Savai et al, 2014; Varma et al, 2014).  
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The Drosophila dFoxO homolog is a highly abundant protein of the airway system (Figure 1-
7). 
 
Figure 1-7: dFoxO expression in the respiratory track of D. melanogaster. The FoxO homolog of the fly is a 
highly conserved gene of the airway epithelium. Beta-galactosidase staining patterns were determined for detec-
tion of dFoxO expression by X-gal staining. Strong lacZ expression is visible in the primary, secondary and 
tertiary branches of the trachea. 
 
The forkhead box O (FoxO) family of transcription factors regulates diverse gene expression 
programs and affects many cellular processes, including cell cycle regulation, cell survival 
and metabolism (van der Horst & Burgering, 2007) and are characterized by a conserved 
DNA-binding domain termed "forkhead box" (Kaestner et al, 2000). Stress stimuli leads into 
translocation of FoxO into the nucleus where it up-regulates a series of target genes.  
In particular, FoxO is negatively regulated by the canonical insulin/insulin-like growth factor 
signaling (IIS) pathway. This cascade is highly conserved among all species possessing an 
insulin receptor (InR), which promotes signaling through the insulin receptor substrates (IRS), 
after binding of insulin or other growth factors. They further activate phosphoinositide-3-
kinase (PI3K) (Coffer et al, 1998; Datta et al, 1999) that phosphorylates inositide lipids on the 
inner surface of the cell membrane, leading to activation of the protein kinase B (PKB) and 
Akt. They then lower the activation of FoxO via phosophorylation and retain it in the cyto-
plasm. In absence of Akt signaling, FoxO is able to activate gene transcription and cause cell 
death after translocation into the nucleus (Arden & Biggs, 2002; Burgering & Kops, 2002). 
Moreover it was shown that different forms of stress, such as hypoxia, also lead into de-
creased phosphorylation of Akt and FoxO3a, correlated with an increased nuclear accumula-
tion (Zhang et al, 2013). FoxOs are also activated in the presence of oxidative stress through 




Members of the core JNK signaling include hemipterous (hep), a JNKK and functional homo-
log of mammalian MKK7, basket (bsk), a JNK, and DJun (Glise et al, 1995; Holland et al, 
1997; Hou et al, 1997; Kockel et al, 1997; Sluss et al, 1996). Activation of JNK pathway in-
duces the expression of puc, which in turn inhibits the JNK (Adachi-Yamada, 2002). FoxO is 
also a key factor of signaling pathways mediating expression of AMPs (Becker et al, 2010). 
Eight classes of AMPs have been unraveled in Drosophila (Lemaitre & Hoffmann, 2007).  
Another important regulation of oxidative stress and toxicity caused by chronic exposure to 
cigarette smoke is the Keap1/Nrf2-signaling (nuclear factor erythroid 2-related factor 2) 
(Motohashi & Yamamoto, 2004). Nrf2 is a transcription factor, which belongs to the 
cap'n'collar (cnc) subfamily of leucine zippers, and Keap1 (Kelch-like ECH-Associated Pro-
tein 1) is the specific repressor for Nrf2. The fruit fly's Nrf2-homolog is therefore called cnc 
gene. In unstressed conditions Nrf2 is tethered to its cytoplasmic inhibitor Keap1, an actin-
binding protein. Keap1 suppresses the activity of Nrf2 by sequestering it in the cytoplasm, 
and also by targeting it for proteasomal degradation. Nrf2 is then stabilized and accumulates 
in the nucleus, where it binds to antioxidant response elements (ARE) in the enhancers of its 
target genes (Jaiswal, 2004). 
Another major innate immune mechanism in Drosophila, and more generally in insects and 
other arthropods, is the melanization reaction (Cerenius & Soderhall, 2004), which is mediat-
ed by a serine protease cascade. A serine protease inhibitor protein, Spn77Ba was reported to 
be the regulator for tracheal melanization (Tang et al, 2008), which regulates the melanization 
cascade through the specific inhibition of the prophenoloxidase-activating enzymes MP1 and 
MP2 that activate phenol oxidase (PO), a key enzyme responsible for melanin biosynthesis. A 
by-product of phenol oxidase activity is ROS.  
Although vertebrates do not possess an equivalent of a phenol-phenoloxidase system (PPO 
system), several studies indicate that the melanization cascade is triggered by injury and half a 
century ago melanotic tumors in Drosophila larvae and adults were viewed as the equivalent 







1.2.4 Advantages of genetic tools for manipulation of the fly's airway epithelium 
A typical advantage seen for genetically tractable invertebrate model organisms is the short 
generation time of approximately 10-12 days at 25°C and an average life span of 50 to 60 
days (Figure 1-8). 
 
Figure 1-8: Generation cycle of D. melanogaster. The shortest development time (egg to adult) of 7 days is 
achieved at 28 °C and can increase at higher temperatures. The eggs hatch 12–15 hours after fertilization. The 
resulting larvae grow for about 4 days (at 25 °C) while molting twice (into second and third instar larvae) at 
about 24 and 48 h after hatching. Further the larvae encapsulate in the puparium and undergo a four-day-long 
metamorphosis, after which the adults emerge. 
 
The maintenance of the flies requires only little labor and is very cost effective compared to 
other animal models. Drosophila offers a great number of highly relevant genetic tools and 
techniques for experimental design that are not found in other animal studies. They can be 
used for genetic manipulation of the airway system thus allowing the study of functional sig-
nificance of target genes. Numerous deletions (Ryder et al, 2007), more than 12.000 transpos-
able element insertions that can be used for genomic mutations (Bellen et al, 2004) and nu-
merous vectors for transgenesis capitalizing on P element are readily available to researchers. 
One versatile and highly useful tool is the binary GAL4/UAS-system invented more than 22 
years ago (Brand & Perrimon, 1993). 
It is a bipartite transcription activation system that relies on the yeast transcription factor 
GAL4 and the corresponding DNA binding region, UAS (upstream activation sequence), used 
for over expression or silencing of specific genes in the tissue of interest. Both components 




The GAL4 line determines the location of expression and the gene of choice is under tran-
scriptional control of UAS elements (Duffy, 2002; Roman et al, 2001). Crossing these two 
lines leads into activation of this system in the entire F1 generation (Figure 1-9).  
Remarkable numbers of GAL4 and UAS lines are available and the Barry Dickson's group 
established a RNAi library for all Drosophila genes, allowing conditional gene inactivation 
(Dietzl et al, 2007). Especially relevant to COPD research there are GAL4 lines that exclu-
sively address the airway epithelium, namely btl-GAL4 and ppk4-GAL4. Until now, these 
lines are restricted to be specifically expressed in the respiratory system of larvae as corre-
sponding driver lines for the adult airway system are not yet available.  
 
 
Figure 1-9: The GAL4/UAS system for targeted manipulation in the fly. The system is ideally suited for 
over expression or silencing (RNAi) of a target gene in a specific organ. It’s a binary system, derived from yeast, 
consisting of a GAL4 that determines location and the UAS effector line that carries the gene to be expressed 
under transcriptional control of the UAS element. In the F1 generation, both factors (GAL4 and the UAS en-
hancer) come together to direct expression of the target gene by the expression pattern of the GAL4 line. There-
by, the target gene is only expressed in a cell- or tissue-specific pattern in their progeny. 
 
A very useful refinement of the GAL4/UAS-system, which allows temporal control of gene 
expression, is the so-called TARGET system (McGuire et al, 2003). This system makes use of 
a temperature-sensitive repressor of GAL4, GAL80
ts
, which is repressing expression under 
low temperature conditions (19° C).  
Inactivation of this repressor is achieved by increasing the temperature to 29° C leading to its 
inhibition and expression of the target gene (Figure 1-10). Such a TARGET expression sys-




Figure 1-10: The Target-system of D. melanogaster. The TARGET system is a method for temporal and re-
gional gene expression targeting (TARGET) with the conventional GAL4-upstream activator sequence (UAS) 
system and a temperature-sensitive GAL80 molecule, which represses GAL4 transcriptional activity at lower 
temperatures (19° C), inhibiting the entire system. At permissive temperatures (29° C) the sensitive repressor 
molecule is inhibited and allows releasing Gal4. 
 
1.2.5 New approaches to manipulate the fly's airways using the DREADD tech-
nology and optogenetic tools to understand airway diseases 
Some examples of recent advanced tools in Drosophila genetics, such as DREADD technolo-
gy and optogenetic tools, open a new era in research to easily activate second messengers or 
to depolarize cell systems. There is a huge number of systems (e.g. temperature sensitive 
TPRA & TRPV channels etc.), thus for this work relevant tools were chosen and are de-
scribed in this chapter. Designer Receptors Exclusively Activated by a Designer Drug 
(DREADDs) are modified muscarinic acetylcholine G-protein coupled receptors that are acti-
vated only by a synthetic ligand, namely by clozapine-N-oxide (CNO) (Armbruster et al, 
2007). These specific modifications were generated by point mutations of specific amino ac-
ids within the GPCRs. DREADD technology combines genetic and pharmacology approach-
es, to manipulate cellular signaling in mammals and has been used for behavioral control 
(Nichols & Roth, 2009). Recently, the Nichols laboratory demonstrated the utility of this 
technology in Drosophila (Becnel et al, 2013). They created three important UAS-DREADD 
transgenes, the UAS-M1D1 that allows inducing the increase of Ca
2+
 levels, UAS-M4D1 that 
decreases cAMP levels and UASM5Dbar that increases the levels of cAMP (Figure 1-11).  
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The activating ligand can be easily and conveniently administered by simply feeding or inject-
ing CNO to the animal.  
 
Figure 1-11: UAS-DREADD transgenes of D. melanogaster. There are three important UAS-DREADD 
transgenes: the UAS-M1D1 to increase Ca
2+
 levels, UAS-M4D1 that decreases cAMP levels and UASM5Dbar 
that increases the levels of cAMP. 
 
This makes the DREADD system a beneficial tool to trigger cAMP and Ca
2+
 in the respective 
tissue using cell specific Gal4 drivers, e.g. PPK4-Gal4 for the tracheal system. 
 
Another powerful technique became possible utilizing light inducible systems, such as 
optogenetic tools, for cell-specific targeting of effector elements. 
The optogenetic approach for cAMP manipulation in vivo can be applied using a small bacte-
rial photoactivated adenylyl cyclase (bPAC), of the soil bacterium Beggiatoa, which possess-
es a BLUF (blue light receptor using FAD) domain (Penzkofer et al, 2014; Stierl et al, 2011). 
Until now in Drosophila research, this system was only applied in neuronal cells and tissues 
and in Drosophila renal (malpighian) tubules for studying cAMP-dependent processes 
(Efetova et al, 2013; Stierl et al, 2011). Thus, utilizing Gal4-driven UAS-bPAC effector lines 
can be another useful tool to study blue-light dependent cAMP increase in the airways of D. 




Figure 1-12: Utilization of photoactivated adenylyl cyclase (bPAC), of the soil bacterium Beggiatoa to 
modulate cAMP in D. melanogaster. Activation of bPAC by blue-light in the respiratory system of the fly 
increases cAMP levels and affects cAMP dependent effectors like protein kinase A (PKA). 
 
Expression of the light-activated ion channel channelrhodopsin-2 (ChR2) of Chlamydomonas 
reinhardtii under UAS control allows depolarization of cells by blue light (480 nm). ChR2 








 ions and therefore was the 
first optogenetic system to control neuronal activity (Nagel et al, 2003). The use of a ChR2 
mutant (D156C) called ChR2-XXL provides extra high expression and long open state and 
can be genetically expressed in any tissue using a specific Gal4-driver of choice (Dawydow et 
al, 2014). When the ion-channel is activated with blue light, the conformational change of the 
channel allows an influx of cations whereas anions cannot pass in (Figure 1-13).  
 
Figure 1-13: Utilization of blue-light activated ChR2-XXL for depolarization of cells in D. melanogaster. 
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The activity of voltage-gated K
+
 channels in pulmonary arterial smooth muscle cells 
(PASMC) is pivotal in controlling membrane potential and cytoplasmic free Ca
2+ 
release 
(Yuan et al, 1998). Cell depolarization and increased intracellular Ca
2+
 concentrations are 
very common in muscular pulmonary arteries of COPD patients (Shimoda et al, 2000; Weir & 
Olschewski, 2006). It was also reported that membrane depolarization causes activation of 
voltage-dependent Ca
2+
 channels, inducing Ca
2+ 
release in smooth muscle cells (Liu et al, 
2009). Thus, applying blue- light induced ion channels ChR2-XXL may help to understand 
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1.3 Aim and significance of the study 
The major aim of this work is to study the impact of cigarette smoke on the airway system of 
D. melanogaster. The mechanism by which cigarette smoke leads to the pathogenesis of 
COPD is currently unclear. Thus, this study attempts to elucidate if D. melanogaster can serve 
as a model organism for assessing the effect of cigarette smoke on airway structure and func-
tion to establish COPD models. Therefore, a further aim of this project is to analyze, which 
major signaling pathways or target genes play a role in the epithelial barrier immunity in re-
sponse to cigarette smoke and what is their potential function for disease development. A 
more detailed characterization of these cigarette smoke regulated genes and their potential 
role for disease development were studied. To unravel transcription factors mediating this 
gene regulation, various fly lines defective in these transcription factors were employed and 
their DNA-binding property was checked by electrophoretic mobility shift assays (EMSA). 
Moreover, airway and lung tissue remodeling play an important role in the development of 
COPD. Thus, it was examined whether CSE leads into morphological changes within the air-
way epithelium.  
Lastly, this study is focused on the roles and functions of second messengers on the physiolo-
gy of the fly's airway system. By employing optogenetic tools, second messenger systems 
such as cAMP, was manipulated in the airway epithelium of D. melanogaster. 
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2. Materials and Methods 
2.1 Materials 
Standard laboratory reagents and materials were obtained from local suppliers, fine chemi-
cals from Sigma if not otherwise indicated and instruments were supplied by the depart-
mental facility.  
 
2.1.1 Laboratory equipments 
All equipments used for this study are listed in Table 2-1. 
 
Table 2-1: List of laboratory equipments 
Item Manufacturer (location) 
Agarose Gel ectrophoresis unit Biometra GmbH, Göttingen, Germany 
Analytical balance ABS Kern & Sohn GmbH, Balingen-Frommern 
Autoclave Steam Sterilizer Varioklav
®
 H+P Medizintechnik GmbH, Oberschleisheim, 
Germany 
Balance MXX-412 Denver Instruments, New York, USA 
Bead Ruptor 24 Omni International, Kennesaw, GA, USA 
Binocular Nikon, Düsseldorf, Germany 
Casting system compact Biometra, Göttingen, Germany 
Centrifuge, 5415 D; rotor: F45-24-11 Eppendorf, Hamburg, Germany 
Centrifuge 5417 R, rotor FA-45-30-11 Eppendorf, Hamburg, Germany 
Centrifuge: Heraeus Fresco 17 Thermo Electron Corporation (Osterose) 
Centrifuge: Sproud  Heathrow Scientific
® 
(Illinois, USA)  
Dryblock & heat bath HB-130 Unitek (Leutenbach) 
Electrophoresis power supply, EV245 Consort, Parklaan, Belgium 
Electrophoresis power supply, EV202 Consort Parklaan, Belgium 
Flourescence microscope Axio Imager.Z1 with 
Axiocam MRM, HXP120 lamp, ApoTome 
Zeiss, Oberkochen, Germany 
Fridge Premium NoFrost CN 3056 CN 3666 Liebherr, Hamburg, Germany 
Savant DNA Speed Vac
®
 DNA 120 Thermo Fisher Scientific Darmstadt, Germany 
Thermostat cabinet 16°C Loviband
®
, Dortmund, Germany 
Thermostat cabinet 25°C Aqua
®
 Lytic, Dortmund, Germany 
Icemachine Manitowoc
®
 Herborn, Germany 
Imager FLA-5000 Fujifilm, Japan 
Incubator 37°C Memmert GmbH & Co.KG, Heilbronn, Germany 
Incubation shaker, Heidolph Unimax 1010 Heidolph Instruments GmbH & Co. KG, 
Schwabach, Germany 
Labcycler  Sensoquest, Göttingen, Germany 
Labguard ES Class II Safety Cabinet IBS Integra Biosciences, Landquart, Schweiz 
Molecular Imager Gel Doc Bio-Rad, Munich, Germany 




Nanodrop ND-1000 spectrophotometer Peqlab, Erlangen, Germany 
Omni Bead Ruptor 24 Omni International Inc, Kennesaw, USA 
oxygen measuring system GOX 100 Greisinger electronic 
pH meter, model 330 Wissenschaftlich-Technische Werkstätten GmbH 
Weilheim, Germany 
Platform Shaker MR Hei-Standard MR 3001 Heidolph, Schwabach, Germany 
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Item Manufacturer (location) 
Pipettes Research Plus  Eppendorf AG, Hamburg, Germany 
pipette controller accu-jet® pro Brand, Wertheim, Germany 
Sonic Ruptor 400 Omni International, Kennesaw, GA, USA 
StepOne Real-Time-PCR System Applied Biosystems, Darmstadt, Germany 
Table autoclave Omni Perfect Beem
®
 , Rosbach, Germany 
Thermomixer HTMR-133 HLC-Heap Labor Consult, Bovenden 
Vortex Genie-2 Scientific Industries, New York, USA 
Water bath, thermostat 2761 Eppendorf, Hamburg, Germany 
Ultraviolet Sterilizing PCR workstation Peqlab Biotechnologie GmbH, Erlangen, 
Germany 
Unitek HB 130 thermo plate Scientific plastic, great britian 
 
2.1.2 List of miscellaneous material 
Miscellaneous material used in this work is listed in Table 2-2. 
 
Table 2-2: Summary of miscellaneous material 
Consumables Manufacturer  
48 wellplate and adhesive film for qRT-PCR Applied Biosystems, Darmstadt, Germany 
Ceapren plugs, 22 mm and 36 mm Greiner Bio-One GmbH, Frickenhausen, Germany 
Disposal bag autoclavable Sarstedt, Nürnbrecht, Germany 
Erlenmayer flasks 5ml, 25 ml, 300 ml DURAN Group GmbH, Wertheim/Main, Germany 
Exam gloves Rotiprotect
®
  Roth, Karlsruhe, Germany 
Fly vials 16 ml & 68 ml Greiner Bio-One GmbH, Frickenhausen, Germany 
NHS-activated Sepharose™  GE Healthcare Life Sciences, Germany 
Serological pitpettes 10ml and 25 ml Sarstedt, Nürnbrecht, Germany 
Steam Indicator Tape, Class I Comply
TM
 , USA 
Sterile filters, ø 0.22 µm  Roth, Karlsruhe, Germany 
Tubes 0,5ml, 1,5ml, 2ml Sarstedt, Nürnbrecht, Germany 
Parafilm "M" Laboratory Film 
PCR Multiply®-Pro tubes 0,2ml Sarstedt, Nürnbrecht, Germany 
PCR tubes 0,2 ml Nerbe Plus, Winsen/Luhe 
Petri dish 140x20 mm Nerbe Plus, Winsen/Luhe 
Pipette tips 20 µl, 200 µl, 1000 µl Sarstedt, Nürnbrecht, Germany 
Precision wipes, Kimberly-clark professional Kimtech science, Canada 
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2.1.3 Chemicals 
All chemicals used for this study are listed in Table 2-3.  
 
Table 2-3: Summary of chemicals and reagents. 
Chemicals Manufacturer (Location) 
1 kbp-GeneRuler
TM
 Fermentas, St. Leon-Roth 
50 bp-GeneRuler 
TM
 Fermentas, St. Leon-Roth 
Acetic acid Carl Roth, Karlsruhe, Germany 
Acryl/Bis 37.5:1; 40% (w/v) Solution Carl Roth, Karlsruhe, Germany 
Agarose Biozym Scientific GmbH, Hessisch Oldendorf 
Ammonium persulfate, > 98 % Carl Roth, Karlsruhe, Germany 
Ampicillin Sigma, Steinheim, Germany 
Antibody dilutent for IHC Aptum Biologics Ltd., Southampton, UK 
Bromophenol Blue, sodium salt Carl Roth, Karlsruhe, Germany 
Chloroform Carl Roth, Karlsruhe, Germany 
Coomassie Brilliant Blue G-250 Carl Roth, Karlsruhe, Germany 
DAPI Invitrogen, Darmstadt, Germany 
Dideoxynucleotides Promega, Mannheim, Germany 
Dimethyl sulfoxide, p. a. Carl Roth, Karlsruhe, Germany 
Dithiothreitol, > 99.5 %  Invitrogen (Karlsruhe) 
Ethanol, p. a. Carl Roth, Karlsruhe, Germany  
Ethidium bromide AppliChem (Darmstadt) 
Ethylene diamine tetraacetic acid Carl Roth, Karlsruhe, Germany 
Glycerol Carl Roth, Karlsruhe, Germany 
Goat serum Sigma-Aldrich, Steinheim, Germany 
Hepes Carl Roth, Karlsruhe, Germany 
Isopropyl alcohol, p. a. Carl Roth, Karlsruhe, Germany 
Isopropyl-β-d-thiogalactopyranoside Carl Roth, Karlsruhe, Germany 
Kanamycin Sigma, Steinheim, Germany 
LB agar (Lennox L agar) Carl Roth, Karlsruhe, Germany 
LB medium (Lennox L broth base) Carl Roth, Karlsruhe, Germany 
L-DOPA Sigma, Steinheim, Germany 
β-Mercaptoethanol, 98 % Carl Roth, Karlsruhe, Germany 
Methanol, p. a. Carl Roth, Karlsruhe, Germany 
Nipagin Carl Roth, Karlsruhe, Germany 
Sodium chloride Carl Roth, Karlsruhe, Germany 
Paraformaldehyde Sigma-Aldrich, Steinheim, Germany 
Potassium chloride Merck 
potassium dihydrogen phosphate  Carl Roth, Karlsruhe, Germany 
dipotassium hydrogen orthophosphate Carl Roth, Karlsruhe, Germany 
RNAmagic Bio-Budget, Kredeld, Germany 
Rotiphorese
®
 Gel 40 (29:1) Carl Roth, Karlsruhe, Germany  
Salmon Sperm DNA Invitrogen 
Section Block solution for IHC Aptum Biologics Ltd., Southampton, UK 
SeeBlue
®
 Plus2 Prestained Standard Thermo Fisher Scientific 
Sodium dodecyl sulfate (SDS), research grade Carl Roth, Karlsruhe, Germany 
Sodium hydroxide (NaOH), p.a. Carl Roth, Karlsruhe, Germany 
N,N, N’, N’-Tetramethylethylene diamine, 99 % Carl Roth, Karlsruhe, Germany 
SYBR® Green Invitrogen, Darmstadt, Germany 
Trichloroacetic acid (TCA), p.a. ≥99 % Carl Roth, Karlsruhe, Germany 
Tris-(hydroxymethyl)-aminomethane (Tris), p. a. Carl Roth, Karlsruhe, Germany 
Triton X-100  Sigma-Aldrich, Steinheim, Germany 
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Chemicals Manufacturer (Location) 
Washing Buffer for IHC Aptum Biologics Ltd., Southampton, UK 
Yeast extracts Carl Roth, Karlsruhe, Germany 
 
2.1.4 Antibodies  
Antibodies, which were used for immunohistochemistry are listed in Table 2-4 for primary 
antibodies and Table 2-5 for secondary antibodies. 
 
Table 2-4: List of primary antibodies. 
Antibodies Source Working dilution 
Mouse α-coracle  Developmental studies Hybridoma Bank, Iowa, 
IA, USA 
1:200 
   
Rabbit α-FoxO Margret H. Bülow (Bulow et al, 2010) 1:200
 
   
Mouse α-WKD gift from Amin S. Ghabrial,  
Dept. of Cell and Developmental Biology,  
University of Pennsylvania School of Medicine 
1:100 
 
Table 2-5: List of secondary antibodies. 
Antibodies Source Working dilution 
Goat α-mouse Dylight 549 Jackson ImmunoResearch Laboratories 1:500 
   
α-mouse Alexa Flour 555 Life Technologies, Darmstadt 1:500
 
   
Goat α-rabbit Dylight 488 Jackson ImmunoResearch Laboratories 1:500 
 
2.1.5 Plasmids and vectors 
A synthetic dFoxo forkhead DNA-binding domain was obtained from Eurofins MWG Operon 
company and synthesized in a pEX-A2 vector. The product was delivered in a lyophilized 
state and therefore was dissolved in 100 μl 10 mM Tris-HCl (pH 8) buffer. All plasmids of 
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Table 2-6: Table of plasmids and vectors.  
Plasmid Description Reference 
pEX
-
A2-FoxO FH DBD size (bp): 2450 Eurofins MWG operon 
 resistence: ampicillin  
 insert: dFoxO_FH with NheI and Hin-
dIII restriction sites, size (bp): 384 
 
   








 desphorylated and digested with NheI 
and HindIII 
 
   
   
pET28a(+) dFoxO FH DBD size (bp): 5689 This work 
 Insert: dFoxO FH   
 resistence: kanamycin  
*) stored at -80°C freezer 
 
2.1.6 Enzymes 
Plasmid DNA was digested with the restriction enzymes NheI and HindIII to isolate the 
dFoxO FH DBD from the pEX-A2 vector and for cloning into pET28a (+) (Section 2.1.5, 
Table 2-6). All digestion reactions were incubated at 37° C for 2.5 h.  
 
Table 2-7: List of restriction endonucleases. 
Name Concentration Restriction site Supplier 
NheI of Neisseria mucosa 
heidelbergensis 







HindIII of Haemophilus 
influenzae Rd 





Thermo fisher  
scientific 
 
Other enzymes used in this study are listed in Table 2-8. 
 
Table 2-8: List of other enzymes. 
Name Supplier 
Taq DNA Polymerase (5 U/μl) Invitrogen, Darmstadt, Germany 
DNAse  Thermo fisher scientific 
RNAse A Thermo fisher scientific 
Proteinase K Thermo fisher scientific  
RNase inhibitor (40U/μl) Invitrogen, Darmstadt, Germany 
T4 ligase Thermo fisher scientific 
SuperScript™III Reverse transcriptase Invitrogen, Darmstadt, Germany 
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2.1.7 Bacterial strains 
In this work the following bacterial strains were used (Table 2-9): 
 
Table 2-9: List of bacterial strains. 
Strain Genotype Supplier 
DH5α F- 80lacZ M15 (lacZYA-argF) U169 recA1 endA1 
hsdR17 (rK–, mK+) phoA supE44 – thi-1 gyrA96 
relA1 












All antibiotics applied in this work are listed in Table 2-10 and were used with following 
concentrations: 
 
Table 2-10: List of antibiotics. 
Antibiotic Stock solution Working concentration 
Ampicillin 100 mg/ml in water 100 µg/ml 
Kanamycin 50 mg/ml in water 50 µg/ml 
Chloramphenicol 34 mg/ml in ethanol 34 µg/ml 
 
2.1.9 Oligonucleotides 
Oligonucleotides used for RT PCR and the purpose of qRT PCR are listed in Table 2-11 and 
were obtained from Eurofins MWG Operon LLC.  
 






















OdT7 I GAG AGA GG ATC CAA GTA CTA ATA CGA CTC ACT ATA GGG AGA (T)25  
T7_fwd TAATACGACTCACTATAGGG 
T7_rev CCCTATAGTGAGTCGTATTA 
*) designed by Christina Wagner, Borstel 
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Oligonucleotides for carrying out electrophoretic mobility shift assays were obtained from 
biomers.net GmbH and listed in Table 2-12: 
 
Table 2-12: List of oligonucleotides used for EMSAs. 
Name Sequence (5` → 3`) Decription 
Upd3_for CACATGTTTTGTTTATCTGCGAGC Cy5 labeled, 8 bp dFoxO FH binding 
motif of upd3 and additionally 8 bp of 
the intergenic region at 5' and 3' 
   
Upd3_rev GCTCGCAGATAAACAAAACATGTG Reverse complement of upd3_for 
   
Upd2_for CAATTAGTGTTTATGGCCTTG Cy5 labeled, 7 bp dFoxO FH binding 
motif of upd2 and additionally 7 bp of 
the intergenic region at 5' and 3' 
   
Upd2_rev CAAGGCCATAAACACTAATTG Reverse complement of upd2_for 
   
Spn77Ba_for GAAGTTTGTTGTTTATTGCACTTG Cy5 labeled, 8 bp dFoxO FH binding 
motif of Spn77Ba and additionally 8 bp 
of the intergenic region at 5' and 3' 
   
Spn77Ba_rev CAAGTGCAATAAACAACAAACTTC Reverse complement of Spn77Ba_for 
 
2.1.10 Solutions and media 
All media and buffers were prepared using deionized water, filtered through an ion-exchange 
unit (Membra Pure) (Table 2-13). All media and buffers were sterilized by autoclaving at 
120° C; the antibiotics were added to the media after cooling to approx. 50° C. 
 
Table 2-13: Solutions and media. 
Medium  Composition 
Buffers for daily use  
  
10 x PBS  1,37 M NaCl  
 2,7 M KCl 
 65 mM Na2HPO4 
 15 mM KH2PO4 
 pH 7.4 
  
HL3 70 mM NaCl 
 5 mM KCl 
 1,5 mM CaCl2 
 20 mM MgCl2 
20 mM Glucose 
 10 mM NaHCO3  
 5 mM Trehalose 
 115 mM Saccharose 
 5 mM HEPES 
 pH 7.2 
  
10 x TBE 0,89 M TRIS 
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Medium  Composition 
 0,89 M bor acid 
 2 mM (Na2)-EDTA 
  
TE 0,01 M Tris 
 0,25 M EDTA 
 pH 8.0 
  
6x DNA loading dye  50% (v/v) glycerol 
 60 mM EDTA 
 6% SDS 
 0.9% bromophenol blue 
pH 8.0 
  
Solutions for X-GAL staining  
  
10 mM sodium phosphate buffer 10 mM NaH2PO4 
 10 mM Na2HPO4 
  
Solution for fixation 0,75 % glutaraldehyde  
  
Staining solution 150 mM NaCl 
 1 mM MgCl2 
 3,1 mM K2[Fe(CN)6] 
 3,1 mM K3[Fe(CN)6] 
 0,3% Triton X-100 
 in 10 mM sodium phosphate buffer 
  
10 % x-GAL stock solution  solve 89 mg in 890 µl DMSO (store at -20° C) 
  
X-GAL staining 25 µl x-GAL in 1 ml staining solution 
  
Normal fly medium  
 1 % agar-agar 
 6.25 % cornmeal 
 6.25 % yeast 
 2 % glucose 
 3 % molasses 
 3 % sugar beet syrup 
 3 % nipagin (10 % v/v)  
 1 % propionic acid (10 % v/v) 
  
Nipagin stock solution  10% (w/v) in 70% ethanol 
  
Propionic acid 10% (v/v) in H2O 
  
Solutions for immunohistochemistry   
  
PFA 4% (w/v) in 1 x PBS, heat at 60-70° C; under 
stirring. cool it down to RT 
 add 0,3% Triton X-100 
  
PBT  0,1 % (v/v) Tween in 1 x PBS 
  
NGS 10 % (v/v) in PBT 
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Medium  Composition 
  
Media for cultivation of E. coli strains  
  
Lysogeny broth (LB) medium  1 % (w/v) tryptone  
 0.5 % (w/v) yeast extract 
 1 % (w/v) NaCl 
 pH 7.4 
 
SOC medium 0.5 % yeast extract  
 2 % (w/v) tryptone 
 10 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
20 mM Glucose 
pH 7.0 
 
1.5 % agar was added to the media for production of agar plates. All media were sterilized at 
121° C for 30 min. LB media was stored at room temperature and SOC medium at - 20° C.  
 
2.1.11 Drosophila stocks 
The fly lines, which were used in this work were usually obtained from the Bloomington 
stock centre and are listed in Table 2-14. 
 
Table 2-14: Flylines used in this study. 





Bloomington No: 5905 
yw
1118 y1 w1118 Bloomington No: 6598 
Knockout lines 
  FoxO-KO  yw;*;dfoxo24/dfoxo24  Marc Tatar, Rochelle, Yamamo-
to 
FoxO-KO w[*]; P-foxo21/foxo21 homozygote Marc Tatar, Rochelle, Yamamo-
to 
Imd-KO w[1118]; Rel[E38] e[s] Bloomington No: 9458 
GFP reporter lines 
  Drosomycin GFP yw (P(w -, drom-gfp)D4, P(ry+, dipt-
lacZ) (162:7)2 
(Tzou et al, 2000)  
10x STAT-GFP 3
rd
  w: 10x STAT-GFP 3rd (Bach et al, 2007) 
10xSTAT-DGFP w[1118]; P{w[+mC]=10XStat92E-
DGFP}3/TM6C, Sb[1] Tb[1] 
Bloomington No: 26200 
unpaired-3  upd3-Gal4;UAS-GFP Perrimon et al., 2003 
GST-D-Reporter  GSTD-Gal4;UAS-GFP Gift from Dirk Bohmann, 
Rochester 
Atf3-EGFP w[*];;pBAC(atf3::EGFP)/TM6B a gift from Colin Donohoe; Co-
logne 
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dSRF-Gal4;UAS-eGFP DSRF-Gal4;UAS-GFP a gift from J. Casanova, IBMB 
CSIC/IRBB, Barcelona, Spain 
Wnt-ERFP fz3-RFP/CyO (Olson et al, 2011) 
UAS responder lines 
  UAS-FoxO in II y[1]w[*];P{w[+mC]=UASfoxo. P}2 Bloomington No: 9575 
pUAS-FoxO-GFP  w[1118]; P{UAS-foxo-GFP} BestGene (Diss. C.Wagner) 
UAS-Dome
CA
 (1;2) w; UAS-dome 2.1 TM-CYT/gowf Perrimon et al., 2003 
UAS-STAT92E P{w[+mC]=UAS-STAT92E) synonym 
UAS-mrl  
Dustin W. Perry, Univ. 
Kentucky  
UAS-Upd3 UAS-upd3, attP40 background BestGene 6727-2-1M 
UAS- HopTum-l y1v1 hopTum/FM7c Bloomington No: 8492 
UAS M1D1  UAS M1D1, insertion on the X chromo-
some 
Charles Nichols Lab (Becnel et 
al, 2013) 
UAS-lacZ P{w[+mC]=UAS-lacZ.Exel}21; 3 Bloomington No: 8530 
pUAST-EYFP-relish P{UAS-Rel.YFP} Tony Ip's lab (Tanji et al, 2010); 
Bettencourt et al. 2004 
UAS-pBAC w[*];P{UAS-bPac.S}/Cyo a gift of Martin Schwärzel; Free 
University Berlin 
UAS-ChR2-XXL y[1] w[1118]; PBac{UAS-
ChR2.XXL}VK00018 
Bloomington No:58374 
(Dawydow et al, 2014) 
UAS-PGRP-LE 8  DDI (Drs-GFP; Dipt.-lacZ):UAS-Flag-
PGRP-LE (II) 
Ihoichiro Kurata 
Gal-4 driver lines 
  PPK4-GAL4 yw67c23; ppk4-Gal4; +/+ (Liu et al, 2003b) 
PPK4- GAL4Gal80
Ts W; GAL4; GAL80, +y GAL4 GAL80  Christina Wagner 
Forschungszentrum Borstel 
c929- GAL4 Insert of  P{GawB}crc929 on 2nd chro-
mosome 
A gift from Christian Wegner 
(Marburg); fly line was generat-
ed by Kim Kaiser, Glasgow 
Cnc- GAL4 w[1118]; P{w[+mC]=GMR36G01-
GAL4}attP2 
Bloomington No: 45241 
Cut- GAL4 w[*]; P{w[+m*]=cut-GAL4.B}3 Bloomington No: 27327 
Puc- GAL4 w[*];P{GAL4E69}puc[GAL4E69]/TM3, 
Sb[1] Ser[1] 
Bloomington No: 6762 
Upd- GAL4  Expresses Gal4 in the pattern of upd BestGene 5070-1-1M*)
 
Upd2- GAL4  Expresses Gal4 in the pattern of upd2 BestGene 5070-2-2M*)
 
Upd3- GAL4  Expresses Gal4 in the pattern of upd3 BestGene 5070-3-2F*) 
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2.2 Methods  
2.2.1 Drosophila culture and crosses 
The flies were raised on standard medium, if not otherwise stated and were kept at 25° C. For 
crossings, 5-15 virgin females of the UAS strains and corresponding GAL4 males in a ratio 
1:2 - 1:3 were used. For crosses with bPAC, 5 males of the UAS strain (straight wings) were 
used and mated with ten virgin females of corresponding GAL4 females. Using the tempera-
ture-dependent Gal4-tubGal80
ts
/ UAS system, gene expression was temporarily controlled. 
For this purpose flies were kept at 17° C and for activating gene expression, the temperature 
was raised to 30° C. The F1-generation of crosses with blue-light inducible strains, were kept 
either in the dark, or the fly vials were covered with aluminum foil to protect them from UV-
light. 
 
2.2.2 Treatment of larvae and flies 
2.2.2.1 Cigarette smoke exposure 
Early third-instar larvae were collected from each genotype and placed in separate vials con-
taining standard Drosophila medium for each CSE treatment. For each experiment the wild 
type and the mutant fly strains to be tested were placed in an air tight smoking chamber at RT. 
The animals were exposed to cigarette smoke by one single cigarette in intervals of 6 hours 
for 1 day (termed as 24 hours CSE) and 2 days, in further text termed as 48 hours CSE. After 
every cigarette the smoking chamber was shortly opened and closed again to ensure an air 
exchange. Additionally, O2 in the smoking chamber was measured to ensure that no hypoxic 
conditions are created (Figure 2-1, Table 2-15).  
 
Table 2-15: Details for smoke exposure. 
  Smoke exposure   
Animals 
(number) 



























For control animals, the vials for each respective genotype were placed in an identical way 
and were exposed to filtered air. The trachea was removed immediately after the treatment for 
gene expression experiments and measurement of the epithelial thickness.  
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The fly vials were sealed with parafilm and holes were arranged with a fine needle to ensure 
that flies are in contact with the smoke. 
 
 
Figure 2-1: Experimental design for application of cigarette smoke on D. melanogaster. Flies and larvae 
were kept in fly vials with media and sealed with parafilm. The surface of the parafilm was punched with small 
holes to ensure gas exchange. Finally, smoke exposure was done by fine-regulation of the water-jet pump creat-
ing a low pressure, which led to cigarette smoke entrance into the chamber. To prevent animals from drying out, 
humidity was maintained with a small bowl of water inside the chamber. 
 
For survival assays of cigarette smoke exposed adult flies, it was important to ensure that the 
flies were all in same age. For this purpose adult flies were kept for another 6 days at 25° C 
after hatching to avoid any effects of CSE on their development in the juvenile stage. The 
flies were subjected to smoke two times a day. Not more than 30 flies of each line were kept 
in a vial to avoid a too high density. The flies were transferred to fresh medium every other 
day, and the number of dead flies was recorded every third day. 
 
2.2.2.2 Hypoxia 
Hypoxia experiments were carried out using an air tight glass exicator, which was supplied 
with a N2 gas. An oxygen electrode was used to measure the O2 level within the exicator, until 
the electrode showed a reading of 3% O2. Humidity was maintained by passing the gas over 
water. The exicator was sealed with parafilm to make sure that there was no exchange of air. 
For gene expression experiments L3 larvae were kept for 1 h at an oxygen level of 2 %.  
For branching experiments, the animals were kept for 2 to 3 days at an oxygen level of 3 %.  
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2.2.2.3 Optogenetic manipulation of the respiratory system with blue light 
In order to investigate the physiological impact of cAMP-dependent signaling in the trachea 
of D. melanogaster, transgenic animals expressing either the photo activated adenylyl cyclase 
(bPAC) or the ion-channel ChR2-XXL were subjected to blue light.  
Transgenic L2 instar larvae were subjected to blue light and raised until L3 in 10% glucose 
and then observed for phenotypic changes. The blue light lamp was arranged approximately 
25 cm above the plate and a lux meter was used for measuring illumination (approximately 
737 lux). Animals expressing the ChR2-XXL were treated in the same way. In order to ensure 
light-induction was only performed by the blue-light, the fly vials were packed in alu foil until 
blue-light was used (Figure 2-2). 
 
Figure 2-2: Schematic view of the in vitro blue light stimulation. Animals of 2nd instar were raised on 10% 
glucose and exposed to blue light until early 3rd instar larval stage to observe changes within the airways of the 
fly. 
 
2.2.2.4 Application of Clozapine N-oxide (CNO) 
To activate DREADD receptors in vivo, CNO was also applied to flies through food. A calcu-
lated amount of this synthetic ligand was dissolved in 1 x PBS to obtain a 10 mM stock solu-
tion. This was mixed with a calculated volume of Drosophila medium depending on the 
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2.2.3 Methods for phenotypical characterization 
2.2.3.1 Survival assay 
Directly after hatching, males and females were separated. Flies hatched within 24 hrs were 
kept for 6 days under control conditions before exposing to cigarette smoke. These flies were 
kept at a density of 30 animals per vial and exposed to smoke. Cigarette smoke exposure was 
performed every day with two cigarettes. The flies were kept in an incubator at 25° C and 
were taken out only for smoke experiments. After every three days, the flies were transferred 
to a fresh medium. Results are represented as percentage of living flies after every 3 days of 
smoke exposure. The statistical analysis of lifespan was performed using the GraphPad Prism 
5 analyzed by log rank test. 
 
2.2.3.2 Immunohistochemistry and microscopy 
Third instar larvae were dissected inside-out in HL3-medium and fixed over night (or for 30 
min at RT) with 4% PFA at 4° C. After three rinses in PBT buffer the tissue was blocked in 
10% NGS and then incubated with the primary antibody overnight at 4° C. Again three rinses 
in PBT followed and the secondary antibody was incubated overnight at 4 C. In all tissue 
samples, nuclei were stained with DAPI and mounted with 80 % glycerol in PBS. All antibod-
ies and their dilutions used for immunohistochemistry purposes are listed in Section 2.1.4, 
Tables 2-4 and 2-5. Microscopic analysis was performed either with an Olympus SZX12 
stereomicroscope, equipped with an epifluorescence support, or images were captured with 
the Zeiss Axio Imager Z1 with Apotome.  
For fluorescent intensity measurement, Zeiss Axio Imager Z1 with Apotome was applied and 
the quantification of cell fluorescent intensity was measured using Image J to calculate the 
corrected total cell fluorescence (CTCF). CTCF= Integrated Density－Area of selected cell × 
Mean fluorescence of background readings (Gavet & Pines, 2010). 
 
2.2.3.3 L-DOPA staining 
Dorsal trunks of third instar larvae were dissected and, after washing in PBS, placed on a 
piece of filter paper pre-soaked in a saturated solution of L-DOPA in PBS.  
The tracheae were submerged in a thin layer of L-DOPA solution and kept at dark room for 
1–2 hrs before observation. 
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2.2.3.4 β-galactosidase staining 
Trachea of L3 instar larvae were isolated in 1xPBS and incubated for at least 25 min in fixa-
tion solution (Section 2.1.10, Table 2-13). After incubation they were rinsed two times for 5 
min with 1xPBS. The tissues were transferred into pre-warmed staining solution (37° C) 
where X-Gal was added. For analytical purposes control flies and crosses were treated in the 
same way. 
 
2.2.3.5 Characterization of tracheal terminal cells 
The region marked with a red circle (3rd segment), has been used for quantification purpose 
of the terminal branches and to observe changes of their morphology (Figure 2-3). 
 
Figure 2-3: Region of interest for characterization of terminal cells. For quantification and characterization 
of the terminal branches, the 3rd segment of 3rd instar larva was chosen as region of interest. 
 
2.2.4 Molecular biological methods 
2.2.4.1 Agarose gel electrophoresis 
Agarose gel electrophoresis was used for analytical and preparative purposes. For a casting 
gel, 1-2 % (w/v) agarose was dissolved by heating it in a microwave oven in 1 x TBE buffer 
and supplemented with 3 μl ethidium bromide. The DNA samples, mixed with 5x DNA load-
ing buffer, were loaded into the wells. DNA size standards (100 bp or 1 kb ladder) were run in 
parallel. Electrophoresis was performed at a constant voltage of 100 V for 45–60 min, de-
pending on the desired resolution. For the purposes of documentation, DNA bands were visu-
alized under UV light (312 nm) and gels were photographed using the gel imaging system. 
 
2.2.4.2 Purification of DNA from agarose gels 
The QIAquick® gel extraction Kit (Quiagen, Hilden, Germany) was used to purify linearized 
vector DNA or PCR products from agarose gels. For preparative purposes selective DNA 
fragments were cut out from stained agarose gels with a scalpel under UV illumination.  
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The gel slices were weighed (= 1 volume) and each slice dissolved in 3 volumes of 
solubilization buffer by incubation for 10 min at 50°C. DNA was purified by using the 
QIAquick PCR purification Kit (Qiagen, Hilden, Germany) according to the manufacturer’s 
instructions. 
 
2.2.4.3 Purification of plasmid DNA 
A small culture (5 ml) of bacteria was grown in order to amplify the plasmid of interest in 
vivo. The bacteria were harvested by centrifugation at 13,000 rpm for 1 min at room tempera-
ture. The resulting pellet was used for the subsequent preparation of plasmid DNA using the 
QIAprep® Spin Miniprep Kit (250) (Qiagen, Hilden, Germany) according to the manufactur-
er's instructions. 
 
2.2.4.4 Restriction endonuclease digestion of DNA 
Type II restriction endonucleases were used to digest double-stranded DNA for analytical or 
preparative purposes. For preparative purposes, 1-5 μg DNA and vector were digested with 1-
20 U of restriction enzymes NheI and HindIII (Section 2.1.6, Table 2-7) in a volume of 10-50 
μl. Complete digestion was confirmed by agarose gel electrophoresis. For analytical purposes, 
0.2-1 μg DNA was digested with 1-5 U of enzyme in a volume of 10 -20 μl. Incubation times 
were varied between 1 and 3 h. Reaction buffers were supplied by the manufacturer. Enzymes 
were heat inactivated as recommended by the supplier or removed by purification of the di-
gested DNA using the appropriate kit. In case of double restriction digestions, the Fermentas 
DoubleDigestTM Online Tool (http://www.fermentas.com/en/tools/doubledigest) was used to 
choose suitable conditions. 
 
2.2.4.5 Dephosphorylation of linearized vector 
In order to prevent self-ligation of vector ends in cloning strategies, 0.5 μl (0.5 U) 
thermosensitive alkaline phosphatase (FastAP) was added to 50 μl digested vector DNA. 
Dephosphorylation was performed in the respective restriction enzyme buffer. Samples were 
incubated for 30 min at 37° C and subsequently purified by agarose gel electrophoresis (Sec-
tion 2.2.4.1) and gel extraction with the MinEluteTM Reaction Cleanup Kit (50), (Qiagen, 
Hilden, Germany). 
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2.2.4.6 Ligation of DNA fragments 
DNA fragments bearing either sticky or blunt ends can be ligated in vitro with bacteriophage 
T4 DNA ligase (5U/μl, Fermentas, GmbH) in 1x Rapid Ligation Buffer (Promega). In a total 
reaction volume of 20 μL, linearized and dephosphorylated vector (50 ng) and insert DNA 
were mixed with a molar ratio of 1:7 (Section 2.2.5, Table 2-6).  
Five units of T4 DNA ligase were added and mixed thoroughly. Ligation mixtures were incu-
bated over night at room temperature and subsequently transformed into competent E. coli 
cells (Section 2.1.7, Table 2-9) or stored at - 20° C.  
In order to check whether the ligation was successful, the plasmid was digested as described 
in Section 2.2.4.4, analyzed by agarose gel electrophoresis and verified via sequencing by 
GATC biotech. 
 
2.2.4.7 Total RNA isolation 
Tracheas of 30 third instar larvae of the respective genotype were dissected in Hl-3 buffer on 
ice. Then 1 ml of RNA magic was added and the samples were frozen in liquid nitrogen and 
thawn on ice. This step was repeated for 2 to 3 times until the trachea were completely ho-
mogenized and 200 μL of chloroform was added. The samples were vortex vigorously and 
incubated for 10 min on ice. After the incubation the samples were centrifuged at 15,000 x g 
for 10 min at 4° C and the upper phase was carefully transferred into a clean tube. An equal 
volume of isopropanol was added for precipitating the RNA over night at - 20° C.  
Then the RNA was centrifuged for 60 min at 17,000 x g, at 4° C and the supernatant was dis-
carded. The RNA pellet was washed for 2 to 3 times with 500 μL 70% ice-cold ethanol by 
centrifugation at 15,000 x g for 5 - 10 min. The Pellet was dried and resolved in 10 μL RNAse 
free water (HPLC water) and stored at - 80 °C. 
 
2.2.4.8 Generation of cDNA and reverse transcriptase PCR 
For the generation of cDNA, 400 ng of total RNA was added into a sterile tube on ice and 
gently mixed with 1 μl Oligo (dT7 I) and 1 μl of 10 mM dNTPs mix (10 mM) with appropri-
ate amount of water. The mixture was incubated at 65 °C for 5 min and immediately placed 
on ice for at least 1 min. Synthesis of cDNA was carried out with SuperScript III reverse tran-
scriptase (Invitrogen) and Ribolock
TM 
ribonuclease inhibitor in each reaction as recommended 
in the manufacturer’s protocols and incubated at 50° C for 1 h.  
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The reaction was terminated at 70° C for 15 min to inactivate the transcriptase. The freshly 
prepared cDNA could be used directly in PCR reaction or frozen at –20° C. Reverse transcrip-
tase PCR was carried out using Taq DNA polymerase in a total volume of 25 μl with gene 
specific primers. The program was processed according to Table 2-16. Subsequently, the 
PCR products were checked by 1 % agarose gel electrophoresis. 
 
Table 2-16: RT-PCR program. 
Cyclus Denaturation 95°C Primer-Annealing 55°C Elongation 72°C  Repeats 
1 1 min --- --- 1 
2 30 sec 30 sec 1 min 30 
3 --- --- 5 min 1 
4  4°C ∞  
 
2.2.4.9 Quantitative real time PCR 
All quantitative RT-PCR analyses were performed using StepOnePlus™ Real-Time PCR Sys-
tem. The total volume of 10 μl, consisting of 5 μl SYBR Green Master Mix, 0.25 μl ROX, 0.5 
μl forward primer (5 μM), 0.5 μl reverse primer (5 μM), 1 μl cDNA (20 ng) and 2.75 μl water, 
was loaded into a 48 well plate. Primers used for qRT-PCR are listed in Section 2.1.9, Table 
2-11. The amplification was run as below:  
 
95 °C   10 min  
95 °C  15 sec  
60 °C   20 sec  40 cycles  
72 °C   35 sec 
95 °C   5 min  
60 °C + 0.3 °C until 95°C melting curve 
95 °C   15 sec 
 
In a preliminary test, the primer efficiencies for both, gene of interest and reference, were 
analyzed based on the standard curve and the slope, which was derived from serial dilutions 
of cDNA from 50 ng to 3.12 ng. The primer efficiencies were calculated according to E=10
-
1/slope
 formula (Pfaffl, 2001). Thus, the relative expression ratio (fold change) of a target gene 
was determined based on E and CT values in comparison to a reference gene. In triplicates, 
the fold changes of each group were represented as mean ± SEM for statistical analysis. In 
this case, Rpl32 served as a reference gene for all assays.  
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The relative expression ratio of the target gene to reference gene was calculated as follows: 
ΔCT = CT target – CT reference, where ΔCT is change of cycle threshold (CT) calculated by 
the StepOne program during amplification. All materials for qRT PCR were treated under UV 
light for 30 min before use. 
 
2.2.4.10 Electrophoretic mobility shift assay (EMSA) 
To create double stranded DNA fragments, an equimolar mixture of complementary Cy5-
labeled oligonucleotides (Section 2.1.9, Table 2-12) were incubated for 5 min at 95° C and 
slowly cooled down to room temperature. Eighty picomoles dFoxO FH and about 10 pmol 
DNA fragments were mixed in binding buffer (12 mM HEPES, 6 mM KCl, 3 mM MgCl2, 1 
mM DTT, 4 mM Tris-HCl, 6 mM EDTA, pH 8.0) to give a final volume of 25 µl.  
Salmon sperm DNA was added as competitor (50 ng/µl, final concentration). After incubation 
at room temperature for 30 min, the samples were separated by 7% acrylamide-bisacrylamide 
[29:1] gel and electrophoresis was carried out in 1xTBE buffer for 1 hour at RT and 120 V. 
Gels were scanned with a Fluoro Image Analyzer FLA-5000.  
 
2.2.5 Microbiological methods 
2.2.5.1 Growth of liquid cultures 
For small liquid culture, 5-10 ml LB/antibiotic medium was inoculated with a single bacterial 
colony and incubated overnight at 37° C on a shaking platform at 250 rpm. The starter culture 
was incubated for 8-12 h and was used to inoculate fresh liquid medium. 
 
2.2.5.2 Growth on solid media 
Dry LB agar plates were used as solid media. Single bacterial colony or bacterial suspension 
was inoculated by spreading with a sterile inoculation loop or a sterile plastic spreader to 
achieve single colony growth. The plates were incubated inverted overnight at 37° C. 
 
2.2.5.3 Monitoring the bacterial growth 
The growth of the bacteria in liquid culture was measured at a wavelength of 600 nm (OD600) 
in plastic cuvettes against pure medium as a blank using a spectrophotometer. Each 0.1 OD600
 
unit corresponds to approximately 10
8
 
cells/ ml for OD600 < 1. 
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2.2.5.4 Heat-shock transformation of plasmid DNA in E. coli 
Treatment of competent bacterial cells (Section 2.1.7, Table 2-9) with a brief heat shock ena-
bles transformation of DNA. Plasmid DNA or a plasmid ligation reaction (not more than 25 
ng) was mixed with 50 μl thawed competent bacteria and incubated for 30 min on ice.  
The bacteria were treated for 90 sec by heat shock at 42° C, placed on ice for 1-2 minutes, 
diluted with 500 μl SOC medium and incubated for 1 h at 37° C with shaking. An aliquot of 
100-300 μl or resuspended pellet was spread on a LB/antibiotic agar plate and incubated 
overnight at 37° C to select clones containing the desired plasmid. 
 
2.2.5.5 Glycerol stocks of E. coli cultures 
For long-term storage of E. coli clones, glycerol cultures were prepared (Sambrook and Rus-
sell, 2001). 2 mL of a fresh overnight culture was chilled on ice and the bacteria were pelleted 
at 10,000 x g for 1 min in a 2 mL tube. Then, 1.2 mL of the supernatants was removed and the 
cell pellets were resuspended in the remaining 0.8 mL.  
200 μL of autoclaved 75 % glycerol were added and mixed by inverting to obtain a final glyc-
erol concentration of 15 % (v/v). Glycerol cultures were stored at -80° C. 
 
2.2.6 Protein expression and purification 
2.2.6.1 Expression of recombinant dFoxO FH DBD 
Transformed host cell BL21 (DE3) with the expression plasmid pET28 a (+) dFoxO FH (Sec-
tion 2.1.5, Table 2-6) were deployed to inoculate 25 ml LB-broth pre-cultures. The cultures 
were grown overnight in an incubator shaker with 250 rpm at 37°C and then utilized to inocu-
late a 500 ml LB large-scale cultures (1:100). Large scale cultures were grown until an optical 
density between 0.6 and 0.8, induced with 0.1 mM IPTG and grown for five hours in an incu-
bator shaker at 250 rpm and 37° C. Afterwards, the cells were collected through centrifuga-
tion in a centra CL3R centrifuge at 4000 g for 20 minutes. The resulting pellets were stored at 
-20° C until protein purification was done. 
 
2.2.6.2 Preparation of cell lysates  
To isolate intracellular expressed recombinant proteins, the thawed cells were resuspended in 
1 x PBS. Then the cells were disrupted using the Omni Sonic Ruptor 400 Watt ultrasonic ho-
mogenizer and cell disrupter for 10 seconds in 4 cycles with a sonification power  70%.  
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Cell debris was removed from the crude lysate by centrifugation in a centra CL3R centrifuge 
at 4000 g for 1 hour at 4° C. 
 
2.2.6.3 Purification of dFoxO FH DBD 
In order to purify soluble fractions of over expressed dFoxO FH DBD, a column was filled 
with NHS-activated Sepharose™ and equilibrated with buffer containing 50 mM NaH2PO4, 
300 mM NaCl and 20 mM imidazole, pH 8.0. The supernatant containing dFoxO FH DBD 
was applied on the equilibrated column and was washed twice with buffer.  
To obtain the target protein in the flow through, an elution buffer containing 50 mM 
NaH2PO4, 300 mM NaCl and 500 mM imidazole, pH 8.0, was used and the target protein was 
collected in 500 µl fractions. The eluted fractions were resolved and analyzed by SDS-PAGE 
(Section 2.2.7). 
 
2.2.7 Protein analysis 
2.2.7.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein samples were incubated under reducing conditions for analytical purposes by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) performed in an electropho-
resis system. SDS polyacrylamide gels were prepared according to the system instructions 
(Table 2-17). SDS-PAGE protein samples were prepared by mixing 20 µl of the protein sam-
ples with 5 µl of 5x SDS sample buffer (Table 2-18). The SDS-PAGE protein samples were 
denatured at 95°C for 10 min and were loaded onto the gel. Electrophoresis was carried out at 
150 V. The resolving gel was subsequently subjected to gel staining (Section 2.2.7.2). By 
comparison with a standard protein marker (SeeBlue
®
 Plus2 Prestained Standard), the molec-
ular weight of the target protein was estimated. 
 
Table 2-17: Composition of stacking and resolving gel. 
Components 
stacking gel 5 % SDS 
(1 ml final volume) 
resolving gel 15 % SDS 
(5 ml final volume) 
Water 0.68 ml 1.1 ml 
30% Acrylamide mix 0.17 ml 2.5 ml 
1.0 M Tris (pH 6.8) 0.13 ml  
1.5 M Tris (pH 8.8)  1.3 ml 
10 % SDS 0.01 ml 0.05 ml 
10 % ammonium persulfate 0.01 ml 0.05 ml 
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Components 
stacking gel 5 % SDS 
(1 ml final volume) 
resolving gel 15 % SDS 
(5 ml final volume) 
TEMED 0.001 ml 0.002 ml  
 
Table 2-18: Composition of 5x SDS sample buffer. 
Components 5x SDS sample buffer 
Bromphenol Blue 0.25 % (w/v)  
Glycerol 50 % (v/v) 
β-Mercaptoethanol 25 % (v/v) 
SDS 4 % (w/v) 
Tris-HCl (pH 6.8) 250 mM 
 
Table 2-19: Composition of SDS buffer. 
Components SDS buffer 
Tris (pH 8.3) 25 mM  
Glycine 192 mM 
Triton X-100 0.1 % 
 
2.2.7.2 Coomassie staining of protein gels 
The polyacrylamide gel was immersed in at least 5 volumes of the coomassie staining solu-
tion and placed on a slowly rotating platform for 30 min at room temperature. The gel was 
destained in coomassie destaining solution on a slowly rotating platform, changing the 
destaining solution three to four times (Table 2-20).  
 
Table 2-20: Composition of coomassie staining and destaining solution. 
Components coomassie staining solution destaining solution 
Coomassie Brilliant Blue G-250 0.1 % (v/v) - 
Methanol 45 % (v/v) 10 % (v/v) 
Acetic Acid 7 % (v/v) 10 % (v/v) 
 
2.2.8 in silico analysis 
2.2.8.1 Sequence collection 
I extracted the genomic DNA/cDNA/protein sequences from flybase by scanning via BLAST 
suite (Altschul & Gish, 1996; Altschul et al, 1990; Altschul et al, 1997).  
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2.2.8.2 Sequence alignment and tree building 
All sequence alignments and tree building were performed with MUSCLE (Edgar, 2004a; 
Edgar, 2004b) using default settings. Sequence information was obtained from the Protein 
Knowledgebase (UniProtKB, www.uniprot.org) available via the Expasy website 
(http://ca.expasy.org). Protein sequence alignments were visualized by Genedoc (Nicholas et 
al., 1997). Phylogenetic analysis was carried out using MEGA4 software (Tamura et al., 
2007) and using the MrBayes 3.2.1 suite (Ronquist & Huelsenbeck, 2003).  
 
2.2.8.3 Structure modeling 
Modeling of the protein structures was performed using I-TASSER (Roy et al, 2010) and sub-




All softwares used in this work are summarized in Table 2-21. 
 
Table 2-21: Applied softwares in this study. 
Tools Websites Purposes 
NCBI protein/DNA 
databases 
http://www.ncbi.nlm.nih.gov/ Retrieving sequences 
BLAST (NCBI) http://www.ncbi.nlm.nih.gov/BLAST/ Homology search 
ClustalW http://www.ebi.ac.uk/Tools/clustalw/index.html Sequence alignment 
Genedoc http://www.nrbsc.org/gfx/genedoc/index.html Alignment editor 
GenTHREADER  
(mGenTHREADER) 
http://bioinf.cs.ucl.ac.uk/psipred/psiform.html Fold recognition 
Expasy www.expasy.de Protein sequence 
analysis 
Psipred http://bioinf.cs.ucl.ac.uk/psipred/psiform.html Secondary structure 
prediction 
GraphPad Prism 5  http://www.graphpad.com/scientific-
software/prism/ 
Comparison of sur-
vival & qRT PCR 
data  
Protein Data Bank (PDB) www.rcsb.org/pdb/ Protein structure 
collections 
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3. Results 
3.1 Activation of JAK-STAT signaling in the trachea after CSE 
GFP reporter lines were used to identify signaling pathways which are getting activated after 
cigarette smoke in the fly's respiratory track, such as Wnt signaling (Appendix 7.1, Figure 7-
1) and JAK-STAT signaling. Third instar larvae of the 10XSTAT92E-DGFP reporter line 
were exposed to cigarette smoke to observe expression of the JAK-STAT pathway. The lar-
vae were exposed to CSE after every 6 hours with 1 cigarette for 2 days, referred as 48 h CSE. 
It is demonstrated that JAK-STAT signaling is getting activated in the trachea in response to 
CSE and may play a physiological role as a key signaling pathway for smoke related disease 
development (Figure 3-1).  
 
 
Figure 3-1: Cigarette smoke exposure on third instar larva of JAK-STAT reporter line. A) Dorsal view of 
cigarette smoke exposed larva. The 10XSTAT92-DGFP reporter (green) detects JAK-STAT pathway activation 
after CSE at the posterior end of the dorsal branches of third instar larvae. Air-exposed larvae served as a con-
trol. B) Filet dissection of animals carrying 10XSTAT92-DGFP confirmed JAK-STAT signaling to be occurred 
at the dorsal branches of the trachea. The scale bar is 100 μm. 
 
Strong GFP expression (green) occurred in treated animals when compared to non-treated 
animals at the dorsal branches as illustrated in Figure 3-1 A. In order to examine if only the 
main dorsal branches were affected, the filet cutting technique was used without destroying 
terminal and secondary branches (Figure 3-1 B). This result indicates that the main affected 
area by cigarette smoke is limited to the dorsal trunks and to a part of the primary branches. 
This illustrates that D. melanogaster was able to absorb cigarette smoke through its airway 
system. 
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Figure 3-2: Dissection of CS-exposed trachea of third instar larvae. A) The reporter line 10XSTAT92-GFP 
was utilized to detect activation of JAK-STAT signaling in the epithelial layer of the dorsal branches (white 
arrows) after CSE. In green: GFP, blue: DAPI and B) DIC light. 
 
The epithelial layer of the dorsal primary branches is the first affected area towards cigarette 
smoke as shown in Figure 3-2 (white arrows). However the general organization of the air-
ways as a single cell-layered epithelium was not affected, because at the parts of JAK-STAT 
pathway activation, cell nuclei are organized in rows along the airways. All together, these 
results corroborate that cigarette smoke evokes an immune response of the epithelial cells at 
this region. 
 
3.2 Activation of the cytokine related ligands upd, upd2 and upd3 
after CSE 
3.2.1 Phylogenetic tree analysis of upd, upd2 and upd3 
The fruit fly's JAK-STAT signaling pathway is simple organized and has three ligands called 
unpaired, namely upd (also called outstreched), upd2 and upd3. Only a few phylogenetic trees 
of the three cytokine-like ligands upd, upd2 and upd3 have been published. However, state of 
art phylogenetic analysis tools have not been used to study their evolution. To comprehend 
the relationship between upd, upd2 and upd3, phylogenetic trees were reconstructed using the 
Bayesian method with MrBayes (Figure 3-3) and maximum likelihood methods (Appendix 
7.2, Figure 7-2) (Ronquist et al, 2012). Similarity searches were conducted against different 
genomes (see materials and method). However, I could not find any homologs in vertebrates 
and other close invertebrate species like Anopheles with the exception of Drosophila species. 
Details of all upd genes are tabulated in Appendix 7.2 Table 7-1.  
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Herein, this study reports an updated list of upd genes of other Drosophila spec., which were 
not described earlier, especially new genomes of D. biarmipes, D. bipectinata, D. elegans, D. 




Figure 3-3: Bayesian phylogeny of the three JAK-STAT ligands upd, upd2 and upd3. Upd, upd2 and upd3 
are Drosophila species-specific genes as depicted by Baysian phylogeny. To date no homologs are found in 
known insect and vertebrate genomes. Upd3 is originated first and phylogenetic analysis suggests that upd and 
upd2 were generated by duplication of upd3 and underwent their own evolution within Drosophila. 
 
Phylogenetic analyses suggest that upd3 is ancestral and originated first to the other two upds 
and that upd and upd2 were generated by duplication. Upd3 underwent its segmental duplica-
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3.2.2 Recognition of a conserved helical cytokine fold of upd3 and IL-6 
As suggested by phylogenetic analysis, the occurrence of invertebrate cytokine-like upds does 
not reflect a common evolutionary origin with other vertebrate cytokines. To date, only little 
is known about the structural properties of the Drosophila upd3. To provide insight into sec-
ondary structural elements of upd3, secondary structures were predicted by PSIPRED (Ap-
pendix 7.3, Fig. 7-3). Although the upds have no sequence similarity to any other known ver-
tebrate cytokines, the predicted α-helices are consistent with an overall structure that is similar 
to several cytokines. They are in high agreement with the predicted structural elements for 
upd3 created by I-TASSER. As illustrated in Figure 3-4 A, highly conserved structural parts 
and alpha helices (H1 - H12) are highlighted in purple. A structural part of the upd3 model, 
which consists of a high α-helical content (H3-H5) shares structural similarity with IL-6 of 
mouse (Figure 3-4 B). Thus, the three-dimensional model provide an insight that upd3 is 
maybe distantly related to IL-6.  
 
 
Figure 3-4: Structural model of upd3 from D. melanogaster. A) The predicted structural model of upd3 by I-
TASSER. Secondary structure predictions by PSIPRED are colored in purple. B) Comparison of the crystal 
structure of IL-6 (PBD: 2L3Y) with upd3 indicates conserved α-helices, which are connected by an "S-X (1)-K-
X (1-2)-L" loop. The alignment shows conserved amino acid residues in black. It's worthful to mention that the 
conserved aa residues are also similarly exposed on the surface. H = α-helices 
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Interestingly, common amino acids of upd3 and IL-6 are also similarly arranged and exposed 
on the surface of the protein.  
 
3.2.3 Expression analysis of upd, upd2 and upd3 in the trachea with and without 
CSE 
The Drosophila cytokines upd 1-3 have been reported to function as ligands of the JAK-
STAT pathway. To determine whether components of the Drososphila cytokine cascade are 
expressed in the trachea, their expression patterns were examined before and after CSE of 3rd 
instar larvae using corresponding promoter-Gal4 lines. To determine the expression of these 
three ligands, the driver lines upd-Gal4, upd2-Gal4, upd3-Gal4 were mated with a LacZ re-
porter line to detect beta-galactosidase production by X-gal staining, without CSE treatment 
(Figure 3-5 A- C) and with CSE (Figure 3-5 E- G). Under control conditions upd was not 
detectable in the fly’s airways, upd2 shows almost no expression in the trachea and upd3 is 
slightly expressed. Interestingly, upd2 and upd3 were strongly expressed in the dorsal trunks 
of the trachea after CSE. In contrast, no expression for upd was observed in the tracheal sys-
tem even under CSE. These results suggest that CSE induces activation of upd2 and upd3 
whereas upd plays a minor role in the cigarette smoke activated response.  
To further evaluate the expression of JAK-STAT signaling, it was of interest to investigate if 
the transmembrane receptor domeless (dome), which is distantly related to the mammalian 
gp130 cytokine receptor, is getting expressed in the respiratory system of the fly. The 
domeless receptor got slightly expressed in the primary branches as well in the secondary 
branches of the airway epithelium in non-treated animals (Figure 3-5 D). Strikingly, after 
exposure to cigarette smoke, the expression pattern of domeless-Gal4 correlates with the ex-
pression pattern of 10XSTAT92E-DGFP, upd2 and upd3 (Figure 3-5 H). This result supports 
the hypothesis that the expression of JAK-STAT signaling at the dorsal branches occurs in an 
autocrine pattern after CSE.  
The additional detection of beta-galactosidase by X-Gal staining demonstrated that upd2 and 










Figure 3-5: Comparison of upd, upd2 and upd3 expression with and without CSE and under hypoxia by 
X-Gal staining. β-galactosidase staining patterns of upd-Gal4, upd2-Gal4, upd3-Gal4 and domeless-Gal4 of 
larval tracheas, without (A, B, C, D) and with CSE treatment (E, F, G, H). For upd2, upd3 and domeless a 
strong lacZ expression was visible in CSE trachea in comparison to their controls. For upd no expression oc-
curred under both conditions. Under hypoxic conditions no expression of upd (I), a strong expression of upd2 (J) 
and a slight expression of upd3 was observed in comparison their controls. The expression for domeless remain 
unchanged under anoxic conditions (L). 
 
Under hypoxic conditions a strong expression of upd2 occured in the secondary and terminal 
branches (Figure 3-5 F). Quantitative RT PCR analysis confirmed a significant up-regulation 
of upd2 after hypoxia (Appendix 7.4, Figure 7-4). 
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3.2.4 Effects of CSE on upd, upd2 and upd3 gene expression in the Drosophila 
airway epithelium 
To verify the results obtained from the expression pattern analysis using β-Gal staining (Sec-
tion 3.2.3), the tracheal RNAs of control and CSE- exposed wild type animals were extracted 
and qRT-PCR analysis was performed, focusing on the three upd-like ligands, upd, upd2 and 
upd3. Their relative transcript levels of the airways were quantified using at least three inde-
pendent biological samples of either control or CSE- exposed animals. To obtain a dose-
dependent response, samples of trachea were taken after 24 hour and 48 h CSE treatment. As 
predicted from the β-Gal staining with upd-, upd2- and upd3-GAL4 (Section, 3.2.3, Figure 3-
5), the differential transcription pattern could be verified for all three ligands by qRT-PCR. 
Upd2 and upd3 show a significant high transcription after CSE, whereas no increased tran-
scription was detected for upd (Figure 3-6). The response to cigarette smoke is higher when 
the dosage increases. 
 
 
Figure 3-6: Relative expression level of upd3 in response to CSE. Transcript levels of upd3 of 3rd instar lar-
vae (w1118) are shown after 24 h and 48 h CSE. Upd3 transcripts were significantly increased in the trachea of 
CSE animals compared to non-exposed animals. Values are means of at least 3 independent experiments ± SEM. 
Y-axis is expressed as the fold change and significances are calculated using the unpaired two-tailed student’s t-
test with *p < 0.05, **p = 0.01 to 0.001, ***p < 0.001, ns p > 0.05. 
 
Similar expression was observed for upd2 after exposure to cigarette smoke. Expression lev-
els significantly increased in comparison to non- smoke exposed animals in the respiratory 
system (Figure 3-7).  
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Figure 3-7: mRNA levels of upd2 in response to CSE. Transcript levels of upd2 of cigarette smoke exposed 
3rd instar larva (w1118) are shown after 24 h and 48 h CSE. Upd2 transcripts were significantly increased in the 
trachea of CSE animals compared to non-exposed animals. Values are means of at least 3 independent experi-
ments ± SEM. Y-axis is expressed as the fold change and significances are calculated using the unpaired two-
tailed student’s t-test with *p < 0.05, **p = 0.01 to 0.001, ***p < 0.001, ns p > 0.05. 
 
There was no significant up-regulation of upd in the respiratory system of the fly in response 
to cigarette smoke (Figure 3-8). 
 
 
Figure 3-8: Relative expression level of upd in response to CSE. Transcript levels of upd of cigarette smoke 
exposed 3rd instar larva (w1118) remain unchanged after 24 h and 48 h CSE in comparison to non-exposed 
animals. Values are means of at least 3 independent experiments ± SEM. Y-axis is expressed as the fold change 
and significances are calculated using the unpaired two-tailed student’s t-test with *p < 0.05, **p = 0.01 to 
0.001, ***p < 0.001, ns not significant p > 0.05. 
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3.3 Activation of proinflammatory transcription factors after CSE 
3.3.1 Relish (IMD) activation after exposure to cigarette smoke 
To identify potential transcription factors, which are involved in the oxidative stress response 
after CSE, transgenic animals were used in which XFP tagged relish (UAS-relish-yfp) and 
dFoxO (UAS-foxo-gfp) are ectopically expressed in the airways. The ppk4-Gal4 driver was 
used to drive expression in the trachea. The nuclear factor of kappaB (NF-ҡB) is one of the 
most important transcription factor involved in airway inflammation. Thus, the expression of 
the fly's homolog relish was examined after CSE. Under normal conditions, relish is localized 
in the cytoplasm of the airway epithelial cells. In contrast, a translocation of GFP-tagged rel-




Figure 3-9: Translocation of the transcription factor relish after CSE. GFP-tagged relish shows a transloca-
tion into the nucleus (white arrows) after confrontation with cigarette smoke (B and D). In control animals, 
relish is present in the cytoplasm (A and C). Panels in blue indicate DAPI staining of the nuclei. Crosses were 
performed using UAS-relish-yfp::PPK4. Shown are merged images of GFP and DAPI. Scale bar is 100 µm.  
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3.3.2 Nuclear translocation of CncC and expression of GstD after CSE 
In order to find out whether the fruit fly's Nrf2-homolog cap'n'collar is getting activated after 
CSE, a GAL4 (under the control of promoter elements of the cnc gene) was crossed with a 
UAS-GFP line, to visualize its expression pattern. A translocation of cncC into the nucleus 
was observed after CSE, as illustrated by nuclear GFP expression (Figure 3-8 A-B).  
Further, a downstream gene of Nrf2, the glutathione S-transferase (GST) was investigated. 
GSTs are induced by Nrf2 activation and represent an important route of detoxification. The 
reporter line GSTD-Gal4;UAS-GFP (Zeng, 2010) was used to monitor its induction. It was 
observed that the GST-D expression was slightly increased in the trachea after CSE (48 h) as 
shown by higher GFP-expression (Figure 3-8 C-D). The expression of GFP was restricted to 





Figure 3-10: Activation of Nrf2-signaling after cigarette smoke exposure. The cap'n'collar transcription fac-
tor Nrf2 translocated into the nucleus after CSE (B) in comparison to control animals (A). Crosses were per-
formed using cnc-Gal4::UAS-GFP. Expression of GST-D was monitored using the GFP-reporter line GSTD-
Gal4;UAS-GFP without (C) and with CSE (D). Panels in blue indicate DAPI staining of nuclei. Shown are 
merged images of GFP and DAPI. Scale bar is 100 µm. 
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3.3.2 Nuclear translocation of dFoxO in response to CSE 
The cellular location of dFoxO was monitored, using transgenic flies for expression of 
dFoxO-GFP. For tracheal localization, the tracheal specific PPK4-GAL4 line was applied. A 
nuclear translocation of dFoxO was observed after exposure to cigarette smoke in comparison 




Figure 3-11: Nuclear translocation of dFoxO after exposure to cigarette smoke. The figure shows isolated 
trachea of control animals, expressing dFoxO-GFP in the cytosol of the airway system driven with PPK4-Gal4 
(A and C), whereas trachea of CSE animals show a translocation of the transcription factor into the nucleus as 
indicated by white arrows (B and D). Panels in blue indicate DAPI staining of nuclei. Shown are merged images 
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3.4 dFoxO dependent regulation of cytokines upd2 and upd3  
3.4.1 Effect of dFoxO and relish knockouts on transcription levels of upd2 and 
upd3 
To unravel the molecular mechanism underlying the immune response to cigarette smoke, 
mutant flies, defective in either relish or devoid of functional dFoxO were used, to evaluate 
the regulation of the cytokine-like upd, upd2 and upd3 following cigarette smoke.  
A reduced expression of upd3 was observed in relish-deficient mutant flies after CSE. No 
significant up-regulation of upd3 was found in dFoxO deficient animals in response to ciga-




Figure 3-12: Relative expression of upd3 in the trachea in dFoxO and relish deficient animals after 48 h 
exposure to cigarette smoke. Upd3 transcript levels were significantly decreased in dFoxO and relish-deficient 
animals after exposure to cigarette smoke in comparison to CS-exposed wild type animals. Values are means of 
at least 3 independent experiments ± SEM. Y-axis is expressed as the fold change and significances are calculat-
ed using one-way ANOVA and the unpaired two-tailed student’s t-test with *p < 0.05, **p = 0.01 to 0.001, ***p 
< 0.001, ns not significant p > 0.05. 
 
 
Animals deficient in dFoxO or relish have shown decreased expression levels for upd2 after 
CSE (Figure 3-13). 
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Figure 3-13: Relative expression of upd2 in the trachea in dFoxO and relish deficient animals after 48 h 
exposure to cigarette smoke. Upd2 transcript levels were significantly decreased in dFoxO and relish-deficient 
animals after exposure to cigarette smoke in comparison to CS-exposed wild type animals. Values are means of 
at least 3 independent experiments ± SEM. Y-axis is expressed as the fold change and significances are calculat-
ed using one-way ANOVA and the unpaired two-tailed student’s t-test with *p < 0.05, **p = 0.01 to 0.001, ***p 
< 0.001, ns not significant p > 0.05. 
 
Expression levels for upd remained unchanged in both mutant flies, before and after CSE 
(Figure 3-14). 
 
Figure 3-14: Relative expression of upd in the trachea in dFoxO and relish deficient animals after 48 h 
exposure to cigarette smoke. Transcript levels of upd under normal and CS-challenged conditions remained 
unchanged in all 3 genotypes (wild type, dFoxO and relish-deficient animals). Values are means of at least 3 
independent experiments ± SEM. Y-axis is expressed as the fold change and significances are calculated using 
one-way ANOVA and the unpaired two-tailed student’s t-test with ns not significant p > 0.05. 
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3.4.2 Characterization of the promoter regions of upd, upd2 and upd3 - screen-
ing for potential dFoxO binding motifs 
As there were no up-regulation for upd3 and decreased transcript levels for upd2 in dFoxO 
deficient flies, it was interesting to examine, if there is a possible regulation of upd2 and upd3 
by the transcription regulator dFoxO. Upon closer look on the promoter regions of upd2 and 
upd3 and after checking for possible dFoxO binding motifs (binding motif: TRTTTAY (R = 
A or G; Y = any with C preferred) several dFoxO DBD motifs were present in the regulatory 
regions of upd2 and upd3 in the forward and reverse strands (Figure 3-15). A highly con-
served binding motif for the transcription factor was detected nearby the predicted promoter 
sides for upd2 and upd3 (shown in a dotted frame). No such motif was found for upd. This 
finding correlates with the qRT PCR data (Section 3.2.4, Fig. 3-14), where no expression of 
upd was observed. These results may indicate a strong regulatory role of dFoxO for upd2 and 
upd3 but not for upd. 
 
Figure 3-15: In silico analysis of the promoter regions of upd, upd2 and upd3. The inspected promoter 
regions of upd2 (B) and upd3 (C), but not that of upd (A) contain several putative binding sites for dFoxO at 
different locations. One of these putative binding sequences (dotted frame) of the promoter upd2 and upd3 was 
chosen to test binding ability of dFoxO FH by EMSAs. 
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3.4.3 Expression and purification of dFoxO FH DBD 
As a next step, the forkhead DNA-binding domain of dFoxO (referred as the term dFoxO FH 
DBD) was cloned into a pET28a (+) expression vector carrying a N-terminal HIS-tag for fur-
ther affinity purification. So far, the FoxO forkhead domain of D. melanogaster, encodes a 
protein that is highly conserved and retains important functional domains found in other FoxO 
homologs of human. The alignment shows dFoxO of D. melanogaster with human FoxOs 1, 
3, 4 and 6. The highly conserved dFoxO forkhead domain (in black shades) was used for 
cloning. The N-terminal start and C-terminal end of the DNA-binding domain is colored in 
green (Figure 3-16).  
 
 
 Dm_FoxO    1 : MMDGYAQEWPRLTHTDNGLAMDQLGGDLPLDVGFEPQTRARSNTWPCPRPENFVE----- :  55 
 Hu_FoxO6   1 : ------MAAKLRAH------------QVDVDPDFAPQSRPRSCTWPLPQPDLAGD----- :  37 
 Hu_FoxO3   1 : MAEAPASPAPLSPL------------EVELDPEFEPQSRPRSCTWPLQRPELQASPAKPS :  48 
 Hu_FoxO1   1 : --------MAEAPQ------------VVEIDPDFEPLPRPRSCTWPLPRPEFSQS----- :  35 
 Hu_FoxO4   1 : MDPGNENSATEAAA------------IIDLDPDFEPQSRPRSCTWPLPRPEIANQ----- :  43 
                                                                                   
 Dm_FoxO   56 : ---------PTDELDSTKASNQQLA----------------------------------- :  71 
 Hu_FoxO6  38 : ---------------EDGALGAGVAEGAED------------------------------ :  52 
 Hu_FoxO3  49 : GETAADSMIPEEEDDEDDEDGGGRAGSAMAIGGGGGSGTLGSGLLLEDSARVLAPGGQDP : 108 
 Hu_FoxO1  36 : -NSATSSPAPSGSAAANPDAAAGLPSASAAAVSADFMSNL--SLLEESEDFPQAPGSVAA :  92 
 Hu_FoxO4  44 : ---------PSEPPEVEPDLGEKVHT---------------------------------- :  60 
                                                                                   
 Dm_FoxO   72 : ------------------PGDSQQAIQNANAAKKN------------------------- :  88 
 Hu_FoxO6  53 : ------------------CGPERRATAPAMAPAPP----------LGAEVGPLRK----A :  80 
 Hu_FoxO3 109 : GSGPATAA-------GGLSGGTQALLQPQQPLPPP------QPGAAGGSGQPRKC----- : 150 
 Hu_FoxO1  93 : AVAAAAAAAATGGLCGDFQGPEAGCLHPAPPQPPPPGPLSQHPPVPPAAAGPLAGQPRKS : 152 
 Hu_FoxO4  61 : ------------------EGRSEPILLPSRLPEPAGGP---QPGILGAVTGPRKG----- :  94 
                         -------H1-----------S1-----H2----------------------       
 Dm_FoxO   89 : -SSRRNAWGNLSYADLITHAIGSATDKRLTLSQIYEWMVQNVPYFKDKGDSNSSAGWKNS : 147 
 Hu_FoxO6  81 : KSSRRNAWGNLSYADLITKAIESAPDKRLTLSQIYDWMVRYVPYFKDKGDSNSSAGWKNS : 140 
 Hu_FoxO3 151 : -SSRRNAWGNLSYADLITRAIESSPDKRLTLSQIYEWMVRCVPYFKDKGDSNSSAGWKNS : 209 
 Hu_FoxO1 153 : SSSRRNAWGNLSYADLITKAIESSAEKRLTLSQIYEWMVKSVPYFKDKGDSNSSAGWKNS : 212 
 Hu_FoxO4  95 : -GSRRNAWGNQSYAELISQAIESAPEKRLTLAQIYEWMVRTVPYFKDKGDSNSSAGWKNS : 153 
                ---H3------S2-       --S3---------------------                     
 Dm_FoxO  148 : IRHNLSLHNRFMRVQNEGTGKSSWWMLNPE-AKPGKSVRRRAASMET-SRYEKRRGRAKK : 205 
 Hu_FoxO6 141 : IRHNLSLHTRFIRVQNEGTGKSSWWMLNPEGGKTGKTPRRRAVSMDNGAKFLRIKGKASK : 200 
 Hu_FoxO3 210 : IRHNLSLHSRFMRVQNEGTGKSSWWIINPDGGKSGKAPRRRAVSMDNSNKYTKSRGRAAK : 269 
 Hu_FoxO1 213 : IRHNLSLHSKFIRVQNEGTGKSSWWMLNPEGGKSGKSPRRRAASMDNNSKFAKSRSRAAK : 272 
 Hu_FoxO4 154 : IRHNLSLHSKFIKVHNEATGKSSWWMLNPEGGKSGKAPRRRAASMDSSSKLLRGRSKAPK : 213 
                                                                                   
 Dm_FoxO  206 : RVEALRQAGVVGLNDATPS-PSSSVSEGLDHFPESPL-HSGGGFQLSPDFRQRASSNASS : 263 
 Hu_FoxO6 201 : KKQ--LQAPERSPDDSSPSAPAPGPVPAAAKWAASPASHASDDYEAWADFRG-------- : 250 
 Hu_FoxO3 270 : KKAA-LQTAPESAD-DSPS--------QLSKWPGSPTSRSSDELDAWTDFRSRTNSNAST : 319 
 Hu_FoxO1 273 : KKAS-LQSGQEGAG-DSPG-------SQFSKWPASPGSHSNDDFDNWSTFRPRTSSNAST : 323 
 Hu_FoxO4 214 : KKPSVLPAPPEGATPTSPV-------GHFAKWSGSPCSRNREEADMWTTFRPRSSSNASS : 266 
                                                                                   
 Dm_FoxO  264 : -CGRLSPIRAQDLEPDWG---------FPVDYQNTTMTQ-AHAQA--------LEELTGT : 304 
 Hu_FoxO6 251 : -GGR--PLLGEAAELEDDEALEALAPSSPLMYPSPASALSPALGSRCPGELPRLAELGGP : 307 
 Hu_FoxO3 320 : VSGRLSPIMASTELDEVQ---DDDAPLSPMLYSSSASLS-PSVSKPCTVELPRLTDMAGT : 375 
 Hu_FoxO1 324 : ISGRLSPIMTEQDDLGEG---DVHSMVYPPSAAKMASTL-PSLSE--------------- : 364 
 Hu_FoxO4 267 : VSTRLSPLRPESEVLAEE---------IPASVSSYAGGV-PP------------------ : 298 
                                                                                   
 
Figure 3-16: Alignment of the dFoxO amino acid sequence with that of human homologues (FOXO1a, 
FOXO3a, FOXO4 and FOXO6). The alignment shows the conserved FH DNA binding domain and its second-
ary structural elements. The major DNA binding helix is colored in red according the proposed structure. Black 
shades indicate amino acids that are identical in all sequences and grey shades highlight conserved substitutions. 
The start and ending amino acid residues of the dFoxO DBD, for cloning purposes, are highlighted in green. In 
yellow: Helices 1 and 2 of the dFoxO DBD and in purple: β-sheets 1-3. 
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So far the FoxO forkhead domain of D. melanogaster is structurally not yet described. Struc-
turally it resembles to those of other species as visualized by a structural model created with I-
TASSER (Figure 3-17 A). Especially the highly conserved helix 3 domain (in red color) was 
shown to be of high importance for DNA-binding in species like human and other vertebrates 
(Tsai et al, 2007). 
 
 
Figure 3-17: Structural model of the dFoxO DBD (A) and the vector map of pET28a (+) dFoxO DBD (B). 
A) The structural model of dFoxO was generated using I-TASSER and visualized by Pymol (http://pymol.org). 
The highly conserved helix 3 domain (H3), mainly important for binding to DNA, is highlighted in red. B) The 
dFoxO DNA binding domain was inserted in a pET28a (+) expression vector for further over expression and 
purification. 
 
The plasmid pEX-A2 dFoxO DBD containing the synthetic gene coding for the dFoxO DBD 
was transformed into E.coli DH5α as described in Section 2.2.5.4. Transformation into DH5α 
was verified by performing agarose gel electrophoresis. The purified plasmid DNA of pEX-
A2 dFoxO DBD (2450 bp) was restricted with NheI and HindIII and yielded into two frag-
ments: a part of the unrestricted plasmid DNA pEX-A2 dFoxO DBD and the dFoxO DBD 
fragment of 384 bp (Appendix 7.5, Fig. 7-5 A). The target gene was purified from the 
agarose gel as described in Section 2.2.4.2 and shown in Appendix 7.5, Fig. 7-5 B. Ligation 
of the gene into a pET28a (+) expression vector was performed as described in Section 
2.2.4.6. The dFoxO DBD gene was inserted directly downstream of the translation signals into 
the NheI and HindIII restriction site of the pET28a (+) (Figure 3-17 B, Appendix 7.5, Fig. 7-
6). In order to check whether the ligation was successful, the plasmid was digested as de-
scribed in Section 2.2.4.4, analyzed by agarose gel electrophoresis and verified via sequenc-
ing by GATC biotech (Appendix 7.5, Figure 7-8).  
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Recombinant pET28a (+) dFoxO FH DBD was transformed into BL21 (DE3) and over ex-
pressed in E. coli BL21. The vector pET28a (+) is under control of the lac operon. Thus, pro-
tein synthesis was induced with 0.1 mM IPTG at an OD600 between 0.5 - 0.7. Non-IPTG in-
duced (t0) cells were used as a negative control.  
Various expression trials were carried out initially, to promote solubility of pET28a (+) 
dFoxO FH DBD. Samples were taken after every hour to control the quantity of dFoxO FH 
DBD (Figure 3-18, A). 
 
 
Figure 3-18: SDS-PAGE analysis of pET28a (+) dFoxO FH DBD - expression in E. coli BL21 (DE3) cells. 
A) Insoluble fractions of over expressed pET28a (+) FH DBD were checked on a SDS-gel after every hour. Lane 
1 (M): molecular weight marker (kDa), t0: cell lysate of uninduced BL21 (DE3) cells possessing pET28a(+) 
dFoxO FH DBD, 1-4 h: cell lysate from induced BL21(DE3) cells containing pET28a (+) dFoxO FH DBD. B) 
Samples of soluble fractions were analyzed of t0, t1 and t4. Samples were taken after every hour and induction 
was carried out with 0.1 mM IPTG, in LB medium at 28°C. Black arrow: dFoxO DBD target protein. The gel 
was stained with coomassie. 
 
Induction at 28°C with 0.1 mM IPTG for 4 hours turned out to be the best expression condi-
tion, which produced soluble protein of dFoxO DBD (theoretical Mw: 16 kDa) (Figure 3-18 
B). The dFoxO FH DBD was purified using a NHS-packed chromatography column. 
The flow through and the eluted fractions from the column were collected and analyzed by 
coomassie staining in a SDS-PAGE (Figure 3-19 A-B) and as described in Section 2.2.5.4. 




Figure 3-19: Purification of soluble dFoxO FH DBD by NHS-chromatography. A) M: molecular weight 
marker (kDA), SN: culture supernatant prior loading onto the NHS-column, FT: flow through, W1 and W2: 
fractions of wash steps. B) M: molecular weight marker (kDA), E1-E7: Fractions of eluted dFoxO DBD protein. 
Black arrow: dFoxO DBD target protein. 
 
Fractions of purified uncontaminated dFoxO protein (Figure 3-19 B, E7) were used for fur-
ther experiments.  
 
3.4.4 Electrophoretic mobility shift assays of dFoxO and upd promoters  
An in silico screening for potential dFoxO binding motifs within the promoter sequence of 
upd2 revealed several putative binding motifs (Section 3.4.2, Figure 3-15). One of these 
binding sequences was chosen to test the physical binding ability of dFoxO DBD. For this 
purpose, the conserved binding sequence nearby the predicted promoter of upd2 and upd3 
was taken. The oligo contained the predicted 7 bp long binding motif plus additionally 7 bp 5' 
and 7 bp 3' end of the intergenic region. To determine whether the dFoxO DBD is capable of 
binding the - 894 bp region for upd2 and -958 bp for upd3, electrophoretic mobility shift as-
says were performed, using over expressed and HIS-tagged purified dFoxO DBD protein 
(Section 3.4.3). As shown in Figure 3-20 A - B, the cy5-labeled double-stranded probes, 









 A) upd 2     B) upd3 
 
Cy5- CAATTAGTGTTTATGGCCTTG  Cy5- CACATGTTTTGTTTATCTGCGAGC 
|||||||||||||||||||||   |||||||||||||||||||||||| 
GTTAATCACAAATACCGGAAC   GTGTACAAAACAAATAGACGCTCG 
 
  dFoxO FH DBD        dFoxO FH DBD 
           
 
Figure 3-20: EMSAs of dFoxO DBD and the promoter regions of upd2 and upd3. EMSA was applied to 
detect the in vitro binding of the dFoxO DNA-binding domain to dFoxO motifs present in the promoter regions 
of upd2 (A) and upd3 (B). The shifted DNA is marked by an arrow. Protein and DNA concentrations were about 
250 ng and 10 pmol, respectively. "+" with and "-" without dFoxO protein 
 
 
3.5 The roles of JAK-STAT signaling in the respiratory tract of Dro-
sophila 
3.5.1 Consequences of ectopic expression of upd3 in the airways 
To investigate the role of upd3 in the trachea of Drosophila, the structural and functional con-
sequences of its ectopic expression were examined, using the tracheal driver PPK4-Gal4. It 
was of interest, if ectopic expression of upd3 can lead into altering of the airway epithelium. 
Interestingly, a remarkable thickening of the epithelial layer was observed (Fig. 3-21 A). This 
result indicates that upd3 might play a role in thickening of the airways and may also be re-
sponsible for triggering epithelial remodeling after exposure to cigarette smoke. In some ani-
mals a narrowing of the dorsal trunks was observed (Fig. 3-21 B). In these regions, the thick-












Figure 3-21: Ectopic expression of upd3 causes remodeling of the airway epithelium. A) The crossing of 
upd3-UAS with the trachea-specific PPK4-GAL4, induced structural remodeling in the airway epithelium. A 
strong thickened epithelial layer was repeatedly observed. Staining of nuclei (DAPI in blue) of those regions 
reveals that they are organized as a monolayer. B) In some animals obstructed regions caused by this thickness 
were visible (white circle). The scale bar is 100 μm. 
 
Quantification of the epithelial thickness and contraction of the primary branches, in compari-




Figure 3-22: Quantification of the thickness and obstruction of the branches after ectopic expression of 
upd3. A) Ectopic expression of upd3 in respiratory system led into structural airway remodeling, in form of a 
thickened epithelial layer. Control animals are characterized by a significant thinner epithelial layer (n = 15). B) 
The primary branches are contracted in animals ectopically expressing upd3 (n = 10). Performed crossing: upd3-
UAS::PPK4-Gal4. Student's t test: *: P < 0.05, **: P < 0.01, ***: P < 0.001, values are means ± SD. 
 
Furthermore, it was interesting to examine, if ectopic expression of other components of the 
JAK-STAT signaling pathway also leads into thickening of the epithelial layer. For this pur-
pose upd and hop
Tum-l
, a dominant gain of function mutation of hopscotch (Yan et al., 1996a), 
were also ectopically expressed in the fly's airways. An epithelial thickness and obstruction 




Figure 3-23: Ectopic expression of upd and hop
Tum-l 
cause thickening of the epithelial layer. The crosses of 
upd-UAS and hop
Tum-l
 with the trachea-specific PPK4-GAL4 induced a structural remodeling in the airway epi-
thelium. A strong thickened epithelial layer was observed after ectopic expression of upd (B) in comparison to 
control animals (A). The same phenotype of epithelial thickness was observed when hop
Tum-l
 was ectopically 
expressed in the trachea (D) in comparison to control animals (C). The arrows indicate the thickening and ob-
struction of the epithelial layer. The scale bar is 100 μm. 
 
3.5.2 Ectopic expression of domeless in the airway epithelium 
During ectopic expression experiments of the constitutive active form of domeless (UAS-
dome
CA
) by using the Gal4-tubGal80
ts
/ UAS system, an epithelial thickness, like it was ob-
served for ectopic expression of upd3, upd and hop
Tum-l
, was not detected. However, ectopic 
expression of the constitutive active form of domeless was lethal to the animals, thus a tem-
perature sensitive system was applied for spatial and temporal expression. Once the animals 
reached L2 instar, the temperature sensitive system was initiated by shifting them to higher 
temperatures and larvae were grown until L3 to analyze epithelial cell formation. The size of 
tracheal epithelial cells was remarkably compressed and the number of cells increased signifi-





Figure 3-24: Ectopic activation of domeless in the trachea using the TARGET system causes structural 
changes. Temporal control of domeless expression was carried out using the temperature-sensitive driver line 
PPK4-Gal4-tubGal80
ts
. Under low temperature conditions (19°C) the system was repressed by Gal80
ts
 (A-C). 
Once the larvae reached L2 instar, a inactivation of this repressor was achieved by putting the animals to 29° C, 
leading to inhibition of Gal80
ts
 and expression of the constitutive active form of domeless gene (UAS-dome
CA
) 
(B-D). Expression of domeless in the respiratory system had an impact on size and number of cells. An increase 




Figure 3-25: Quantification of the cell size and number in animals ectopically expressing domeless in the 
trachea. Ectopic expression of dome using a temperature sensitive PPK4-Gal4/Gal80
ts
 driver leads to a higher 
number of nuclei within the trachea (in black) in comparison to control tracheas (in grey) (A) and size of epithe-
lial cells were significantly decreased in comparison to control animals (B). Student's t-test: * p ≤ 0.05; ** p ≤ 
0.01; *** p ≤ 0.001; ns not significant. Number of animals: 20.  
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The number of nuclei was higher in animals ectopically expressing the constitutive active 
form of domeless but maintained normal size, as displayed and quantified by DAPI staining 
(Figures 3-24 and 3-25 A). Epithelial cells were stained with α-coracle and allowed quantifi-
cation of their sizes (Figure 3-25 B). Other structural malformations in the respiratory tract of 
these larvae were strongly melanized tracheal branches, hinting that the larvae were dying due 




Figure 3-26: Ectopic expression of domeless in the fly's respiratory system causes malformation of the 
trachea and melanization. Domeless-UAS was crossed with the trachea specific PPK4-GAL4 driver, which 
induced a structural remodeling in the airway epithelium. The tracheal system was completely malformed and 
branches were characterized by strong melanization.  
 
3.6 Cigarette smoke exposure induces local remodeling in the airway 
epithelium 
Cigarette smoke reduces epithelial barrier function, impairs wound healing and leads into 
thickening of the epithelial cells. In cigarette smoke exposed larvae a thickening of the epithe-
lial layer was observed at the same location where activation of JAK-STAT signaling oc-
curred as displayed by the upd3-Gal4;UAS-GFP line (Figure 3-27 A-B). Especially at the 
dorsal branches, where GFP expression was enhanced, the thickness was significantly in-





Figure 3-27: Airway remodeling in response to cigarette smoke. Strong GFP expression of CS-exposed lar-
vae of upd3-Gal4;UAS-GFP occurred at the dorsal trunks as indicated by an white arrow (A and B). These re-
gions were characterized by a strong thickening of the epithelial layer after CSE (C). Quantification of the thick-
ness was performed using student's t-test: *: P< 0.05; **: P< 0.01; ***: P< 0.001 (D). Values are ± SD, n = 15 
and the scale bar is 100 µm. 
 
Additionally, a strong GFP expression was visible in the oenocytes of CSE animals in com-
parison to non-smoke exposed animals, indicative for upd3 expression (Figures 3-28 A-B, 
and 3-28 D). A dissection of the oenocytes revealed that they are directly connected to the 
larvae's terminal branches (Figure 3-28 C). Stronger GFP signals were also detected in the 





Figure 3-28: Activation of upd3 in the oenocytes after CSE. A strong GFP signal was displayed in the 
oenocytes in CS-exposed larvae in comparison to control animals (A and B). Dissection of these oenocytes 
shows that they are directly connected to the terminal branches of the fly's airway system (C). Measuring of cell 
fluorescence (corrected total cell fluorescence (CTCF) vs. integrated density (IntDen)) was performed using 
ImageJ and confirmed an increase of GFP in oenocytes of smoke-exposed larvae (D). Student's t-test with *: 
P<0.05; **: P<0.01; ***: P<0.001, values are ± SD, n=15. The scale bar is 100 µm. 
 
Another form of airway remodeling was observed in the terminal branches of CS-exposed 
animals. The terminal branches occurred to be curlier after CSE in comparison to their con-
trols, as shown by staining with α-WKD antibody (Appendix 7.6, Figure 7-9). 
 
3.7 Cigarette smoke exposure reduces life span of D. melanogaster 
In earlier studies it was shown that one cigarette each day reduces the lifespan of the fly by 
almost 50% (Kallsen, 2013). Therefore, it was interesting to examine, if a higher number of 
cigarettes enhances the toxical effect on lifespan. For this purpose, 100 flies of each genotype 
(wildtype and flies deficient in dFoxO or relish) were taken and exposed with two cigarettes 
per day. Survival curves of female and male flies of the wildtype exposed to cigarette smoke, 
significantly shifted to the left (Figure 3-29 A and B). 
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For cigarette exposed male flies, the median survival was significantly decreased by 66.7%. 
The median survival time for CSE female flies was shortened by 66% compared to the control 
(Log-rank test: p< 0.001). The medium survival time was 15 d for smoke exposed male and 
18 d for female flies. There was no change in the median survival of female and male flies 
under physiological conditions (45 days).  
 
 
Figure 3-29: Lifespan of male and female wild type flies after CSE. Smoke exposed female (A) and male 
flies (B) lived 66.7% and 66.6% shorter than the control flies respectively. In smoke exposed male flies the me-
dian survival time is 15 days (n=102) and in female flies 18 days. The median survival for controls of both sexes 
is 45 days (n=100). Log-rank test for survival analysis showed that p< 0.001 for both sexes. Control flies are 
shown with a dotted line. 
 
Further, it was of interest if there is any difference in mortality behaviour of flies deficient in 
relish or dFoxO. To rule out, if flies deficient in dFoxO may die faster, I performed a survival 
assay with dFoxO deficient flies. Smoke exposed dFoxO-deficient flies had a remarkable de-
crease in lifespan compared to their non-exposed counterpart (Figure 3-30 A and B). The 
median survival was significantly decreased by 50% for the male and by 53.8% for female 
flies compared to their controls (Log-rank test: p<0.001).  
 
 
Figure 3-30: Life span of flies deficient in dFoxO after CSE. Smoke exposed female (A) and male flies (B) 
deficient in dFoxO lived 53.8% and 50% shorter than their controls, respectively. For both sexes the median 
survival time was 18 days for smoke exposed animals (n=100). The median survival was 39 days for control 
female (n=100) and 36 days for control male flies (n=100). Log-rank test for survival analysis showed that 
p<0.001 for both sexes.  
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However, under normal conditions the life span of dFoxO deficient flies is lower than that of 
the wild type flies (female and male) whereas after exposure to cigarette smoke, dFoxO defi-
cient flies seems to live slightly longer than the wild type (Figure 3-31 A - B). 
 
 
Figure 3-31: Life span comparison of wild type and dFoxO deficient flies. Female (A) or male (B) dFoxO 
deficient flies (white triangles) show a large decrease in lifespan under normal conditions (ctrl), when compared 
to wild type flies (white balls). Interestingly, dFoxO deficient animals seemed to be more tolerant towards ciga-
rette smoke (black triangles) when compared to smoke-exposed wild type animals (black balls) for both sexes. 
Data derived from Log- rank analysis *: P < 0.05, *** P < 0.001. 
 
At last, I subjected animals deficient in relish to cigarette smoke. These mutant flies showed a 
significantly decreased survival rate compared to wild type flies in both conditions. Relish 
deficient flies had a decreased natural lifespan compared to wild type flies for both sexes. In 
cigarette exposed male flies deficient in relish, the median survival was significantly de-
creased by 55.6% (Log-rank test: p<0.001) and shortened by 42.9% in female flies compared 





Figure 3-32: CSE decreased life span of relish deficient flies. Smoke exposed female (A) and male flies (B) 
deficient in relish TF lived 42.85% and 55.55% shorter than their controls, respectively. In both sexes the median 
survival time was only 12 days for smoke exposed animals (n=100). The median survival was 21 days for con-
trol female (n=100) and 27 days for control male flies (n=100). Data derived from Log- rank analysis (p<0.001) 
of the survival curves.  
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3.8 Expression of drosomycin in response to cigarette smoke expo-
sure 
To visualize expression of the major antimicrobial peptide genes in response to cigarette 
smoke, reporter lines were used, carrying promoter::gfp fusions of drosomycin, defensin, 
drosocin, attacin, metchnikowin and diptericin (Ferrandon et al, 1998; Tzou et al, 2000). The 
larvae were scored for the presence of GFP expression in the tracheal system after a challeng-
ing condition with smoke. Interestingly, only drosomycin was found to be expressed after 
CSE in the entire trachea of 3rd instar larvae (Figure 3-33 A-B) whereas no GFP was ob-
served for defensin, drosocin, attacin, metchnikowin and diptericin (data not shown) neither in 
larvae nor in adult flies.  
 
 
Figure 3-33: Activation of the antimicrobial peptide drosomycin in response to CSE. Following exposure to 
CSE, the anti-microbial peptide drosomycin was released in the trachea (A) and was also found to be expressed 
in the secondary and tertiary branches (B). 
 
3.9 Induction of cAMP synthesis in the airways of D. melanogaster 
by a blue light activated adenylyl cyclase of Beggiatoa (bPAC) 
3.9.1 Sequence similarity between Beggiatoa bPAC and Drosophila Gyc76C 
Another part of my thesis was to study, how alterations of cAMP levels affect the physiology 
of the airways in Drosophila. Until now, only little is known about how higher levels of 
cAMP affect the airways. In contrast much is known about cAMP degradation in context of 
COPD pathogenesis. The recently found adenylyl cyclase of Beggiatoa (bPAC) seemed to be 
a powerful tool for optogenetic manipulation of the fly's respiratory track via activation by 
blue light. Its expression and activation was tested in several tracheal parts with help of dif-
ferent tracheal Gal4-drivers.  
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A BLAST search using bPAC coding sequence of Beggiatoa identified a distant homologous 
gene in the Drosophila genome, the guanylyl cyclase Gyc76C and the human natriuretic re-
ceptor. The alignment of bPAC, Gyc76C and the natriuretic receptor indicates that these cata-
lytic domains and their structural organization are tightly conserved within the adenylate and 
guanylate cyclase catalytic domain (Guanylate_cyc, Pfam Id - PF00211) (Figure 3-34).  
 
                                                                                    
bPac_Beggiatoa    98 : -LNENSELMIQPIKSLLQTITQSHRVLEKYMPARVIYLINQGINPLTVEPQLVEKI-IFF 
Dm_cyc76c        827 : YANNLEDIVTERTRLLCEEKMKTEDLLHRMLPQSVAEKLTMG---QGVEPVSYDLVTIYF 
Hs_NatriureticR  843 : YANNLEELVEERTQAYLEEKRKAEALLYQILPHSVAEQLKRG---ETVQAEAFDSVTIYF 
                        Me                                          Me              
                        ▼                                          ▼               
bPac_Beggiatoa   156 : SDILAFSTLTEKLPVNEVVILVNRYFSICTRIISAYGGEVTKFIGDC--VMASFTKEQGD 
Dm_cyc76c        884 : SDIVGFTAMSAESTPLQVVNFLNDLYTVFDRIIRGYDVYKVETIGDAYMVVSGLPIKNGD 
Hs_NatriureticR  900 : SDIVGFTALSAESTPMQVVTLLNDLYTCFDAVIYNFDVYKVETIGDAYMVVSGLPVRNGR 
                                                                                    
                                                                                    
bPac_Beggiatoa   117 : ----AAIRTSLDIISELKQLRHHVEATNPLHLLYTGIGLSYGHVIEGNMGSSLKMDHTLL 
Dm_cyc76c        944 : RHAGEIASMALELLHAVKQHRIAHRPNETLKL---RIGMHTGPVVAGVVGLTMPR-YCLF 
Hs_NatriureticR  960 : LHACEVARMALALLDAVRSFRIRHRPQEQLRL---RIGIHTGPVCAGVVGLKMPR-YCLF 
                           Tr  Tr                                                   
                           ▼  ▼                                                    
bPac_Beggiatoa   173 : GDAVNVAARLEALTRQLPYALAFTAGVKKCCQ---AQWTFINLGAHQVKGKQEAIEVYTV 
Dm_cyc76c       1000 : GDTVNTASRMESNGEALK--IHISNKCKLALDKLGGGYITEKRGLVNMKGKGDVVTWWLT 
Hs_NatriureticR 1016 : GDTVNTASRMESNGEALK--IHLSSETKAVLEEF-GGFELELRGDVEMKGKGKVRTYWLL 
                                                                                    
                              
bPac_Beggiatoa   326 : NEAQK- 
Dm_cyc76c       1059 : GANENA 
Hs_NatriureticR 1073 : GE---- 
                              
 
Figure 3-34: Sequence alignment of bPac of Beggiatoa with Drosophila Cyc76c and the human natriuretic 
receptor. A part of the bPAC sequence was aligned to the corresponding regions of other cyclases obtained from 
BLAST search. The closest homolog was Drosophila Cyc76c and the natriuretic receptor of human. The highly 
conserved region of all 3 proteins is highlighted in black. In grey boxes are shaded conserved substitutions, met-
al-binding Asps (Me) are shaded in blue and transition state-stabilizing Asn and Arg are in green (Stierl et al, 
2011).  
 
3.9.2 Expression and activation of bPAC controls tracheal terminal branching 
The formation of the terminal branches is regulated by the gene DSRF/ blistered, a Drosophi-
la homolog of the serum response factor. DSRF/ blistered is specifically expressed in the ter-
minal branches. Expression and blue-light activation of bPAC in the terminal branches with 
help of DSRF-GAL4, had a remarkable impact on the branching phenotype of the airways. 
Changes in branching were observed and monitored in the 3rd segment of 3rd instar larvae in 
dorsal view of blue-light induced animals under normoxic (Figure 3-35 D - F) and hypoxic 
conditions (Figure 3-35 G - I). Blue-light exposure inhibited branching remarkably and led 





Figure 3-35: Activation of bPAC by blue light in the terminal branches under normoxic and hypoxic con-
ditions. Blue-light activation of bPAC in the terminal cells inhibited branching and led into disorganized pattern-
ing of the terminal cells (D, E, F) in comparison to control animals (A, B, C). Subjecting these animals to hy-
poxic conditions could not initiate branching (G, H, I). For counting of branches the 3rd segment of 3rd instar 
larvae, dorsal view was chosen and crosses were performed using bPAC::DSRF-GAL4;UAS-GFP, scale bar: 
100 µm. 
 
Terminal branching is highly variable and regulated by the oxygen supply. Thus, bPAC acti-
vated larvae were allowed to grow under anoxic conditions in order to promote an increase in 
terminal branching. The result shows that hypoxia could not significantly enhance branching 




Figure 3-36: Number of terminal branches after activation of bPAC by blue light under normoxic and 
hypoxic conditions. The number of branches was remarkably reduced after exposure to blue light. For counting 
of branches: third segment of 3rd instar larvae, dorsal view. Crosses carried out were: bPAC::DSRF-Gal4; UAS-
GFP. Number of animals: 20. Significances are calculated using student's t-test with * p<0.05, ** p = 0.01 to 
0.001, *** p < 0.001, ns not significant p > 0.05. 
 
In some animals an incorrect positioning of the terminal branches after activation with blue 
light was observed (Figure 3-37). 
 
 
Figure 3-37: Malformation of terminal branches by activation of bPAC by blue light. Some larvae were 
characterized by malformed branches. The third tracheal segment of 3rd instar larva, dorsal view was used to 






3.9.3 Expression and activation of bPAC causes melanization in the airways 
Activation of bPAC in the respiratory system of the fly, using various trachea-specific GAL4-
lines, resulted into melanized branches. Expression and blue-light activation of bPAC in the 
terminal cells displayed incorrect patterning of the terminal cells and melanized, lumpy cells 
(Figure 3-38 A-D).  
 
Figure 3-38: bPAC induced activation of cAMP in the terminal branches leads into melanized lumps. All 
animals of the crosses bPAC::DSRF-Gal4; UAS-GFP were characterized by melanized branches (A-B). The filet 
cut of tracheas show lumpy, melanized tracheal cells (C-D). The scale bar is 100 µm. 
 
In addition, elevation of cAMP levels by bPAC, using a Gal4-driver specific for the inca-
cells, did not induce any significant changes in the airway epithelium. This could be explained 
by the moderate activity of the driver line.   
An expression and activation of bPAC crossed with the PPK4-driver led into tracheal 
melanization in instar L1-L3 (Figure 3-39 A). Overall, melanization was observed in all ani-
mals carrying blue-light induced bPAC transgene (Figure 3-39 B), except for crosses with the 




Figure 3-39: Activation of bPAC by blue light in the trachea driven by PPK4-GAL4 leads into 
melanization. A) Expression and blue-light activation of bPAC in the respiratory track using PPK4-Gal4 causes 
melanization in all instar 1-3. B) All animals are characterized by melanized branches and significances are cal-
culated using student's t-test with **p = 0.01 to 0.001, ***p < 0.001, NS p > 0.05. 
 
3.9.4 Expression and activation of bPAC in the airways controls growth and vi-
ability 
Blue-light induced bPAC in the respiratory system regulates larval growth and viability. First 
instar larvae of bPAC::PPK4, could maximum complete L2 instar after direct exposure to 
blue light. In those animals, a complete larval lethality was observed (Figure 3-40 A-B). The 
larvae show a behavior that is typically seen in animals that experience severe oxygen cut-
back. They left their medium prematurely and died as early larvae. (Figure 3-40 B). A closer 
look on these larvae reveals that numerous epithelial cells are not functional any more. Dam-
age is visible in form of melanization and a disturbed structure of the airways. 
 
 
Figure 3-40: Activation of bPAC by blue light with the tracheal driver PPK4-Gal4 has impact on growth 
phenotype and viability at the L1/L2 transition. A) Activation of bPAC in the entire trachea using PPK4-
Gal4, has remarkable effect on larvae‘s development. Most of the animals were able to reach L2 but they died as 
early larvae after direct application of blue light. B) These transgenic animals left their medium prematurely. 
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3.9.5 Expression and activation of bPAC in the trachea effects the homeobox 
transcription factor cut 
Next, investigation was carried out for the role of cAMP activation with a driver line of the 
homeobox transcription factor cut. The homeobox transcription factor cut coordinates pattern-
ing and growth during Drosophila airway remodeling (Pitsouli & Perrimon, 2013). The ex-
pression and blue-light activation of bPAC in the trachea using cut-Gal4, had dramatic effects 
on the phenotype at the dorsal branches. This activation had a strong impact on development 
and growth of the branches. Branches at these regions were completely malformed and their 




Figure 3-41: Expression of the photoactive bPAC transgene using cut-Gal4 leads into malformed dorsal 
branches. Activation of bPAC in the fly's airways with blue light, utilizing the cut-Gal4 driver, affects pattern-
ing and growth of the dorsal branches. Branching was significantly inhibited in the last segment of the trachea. 
Scale bar: 100 µm, crosses were performed using bPAC::cut-GAL4. 
 
Additionally, regions of activated bPAC were characterized by strong epithelial thickness and 





Figure 3-42: Expression of the photoactive bPAC transgene using cut-Gal4 causes thickening and 
melanization of the dorsal trunks. Activation of bPAC by blue light, using the cut-Gal4 driver, initiated airway 
remodeling in form of a thickened epithelial layer at the dorsal trunks (A-C). Moreover, this part is also charac-





Figure 3-43: Quantification of the epithelial thickness of blue-light activated animals. Airway remodeling in 
form of a significant thickening was visible in blue-light exposed animals in comparison to animals not exposed 
to blue-light. Crosses: cut-Gal4::bPAC and data are presented as mean ± SEM, student's t-test: * p ≤ 0.05; ** p ≤ 
0.01; *** p ≤ 0.001. Number of animals: 15. 
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A closer look on these nuclei shows that transgenic animals expressing bPAC under control of 
cut-Gal4 possess higher number of nuclei compared to control animals (Figures 3-44 and 3-
45). 
 
Figure 3-44: Expression of the photoactive bPAC transgene using cut-Gal4 causes a higher number of 
nuclei. Activation of blue-light inducible bPAC using the cut-Gal4 driver, led into an increased number of nuclei 
as visible by DAPI staining, which indicates higher proliferation rate of these cells (C-D) in comparison to con-




Figure 3-45: Quantification of nuclei number. Activation of blue-light inducible bPAC using the cut-Gal4 
driver increased the number of nuclei 1.5-fold. 
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These results indicate that in these transgenic animals the proliferation of cells is increased. 




Figure 3-46: Expression of the photoactive bPAC transgene using cut-Gal4 leads to proliferation of cells 
and decreased cell size. Activation of bPAC by blue light, utilizing the cut-Gal4 driver, increased number of 
cells and decreased cell size significantly (B and E) in comparison to control animals (A), as observed by α-
coracle staining (red). This indicates for a higher proliferation rate of these cells. A thickening of the airway 
epithelium was repeatedly observed and staining of nuclei by DAPI (blue) revealed that they are organized as a 
monolayer at these regions (C - D). Moreover, the size of nuclei was increased (F). Scale bar: 100 µm, crosses 




3.9.6 Expression and activation of bPAC in the trachea leads to activation of 
dFoxO 
Interestingly, exposure of bPAC transgenic animals to blue light utilizing cut-Gal4, had an 
impact on the activation of the transcription factor dFoxO in the airways. A translocation of 
dFoxO into nucleus was observed (Figure 3-47). 
 
 
Figure 3-47: Activation of the transcription factor dFoxO in blue-light activated bPAC animals. Activation 
of bPAC by blue-light, utilizing the cut-Gal4 driver, resulted into nuclear translocation of dFoxO (green) (A and 
B) in comparison to control animals where dFoxO was found in the cytosol (C and D). DAPI-staining (blue) and 
α-FoxO staining (green), crosses were performed using bPAC::cut-GAL4, scale bar: 100 µm. 
 
Similar phenotypes of cell size deduction and translocation of the transcription factor dFoxO 





Figure 3-48: Expression of the photoactive bPAC transgene using PPK4-Gal4 resulted into dFoxO trans-
location and decreased epithelial cell size. Activation of bPAC by blue light in the entire trachea, using PPK4-
Gal4, resulted in nuclear translocation of dFoxO into the nucleus (A and B) but not for control animals (C and 
D). A compressed epithelial cell size is visible as shown by α-coracle staining (red, white arrow) (G) in compari-
son to control animals (F), which indicates for a higher cell proliferation. DAPI-staining in blue and α-FoxO 







3.10 Depolarization of the terminal cells utilizing ChR2-XXL 
Further, the branching plasticity after depolarization of the tracheal cells was explored, using 
the blue-light inducible ion-channel ChR2-XXL. Depolarization of the terminal cells by 
ChR2-XXL using DSRF-GAL4;UAS-GFP, leads into 3 malformed branches in comparison to 
all control animals possessing naturally 2 branches (Figure 3-49). This result underlines the 
importance of a balanced cell polarity within the respiratory track. Minor changes can lead 




Figure 3-49: Blue-light activation of ChR2-XXL in the terminal branches. Expression of the blue-light-
inducible ion channel ChR2-XXL in the terminal branches resulted in three sprouting branches (B and D) com-




3.11 Melanotic tumor formation in the respiratory track of D. mela-
nogaster  
Until now, there is only one pathway, which fully describes how melanization can be activat-
ed in the trachea under tight negative control by a serpin protease inhibitor (Spn77Ba).  
My results show that translocation of the transcription regulator dFoxO takes part in the bio-
synthesis of melanin within the respiratory system of the fly and thus could be a new un-
known pathway to regulate melanization. Ectopic expression of dFoxO in the larvae trachea 
resulted into dramatic changes of the overall epithelial structure and induces melanotic tu-
mors.  
 
3.11.1 Activation of dFoxO leads into tracheal melanization  
Ectopic expression of dFoxO in the airways of the fruit fly driven by PPK4-Gal4 resulted into 
melanized sections of the trachea (Figure 3-50). For this purpose dFoxO-UAS was mated 
with the driver lines PPK4-Gal4 and DSRF-Gal4. The cells expressing dFoxO were character-
ized by the synthesis of melanin and a translocation of dFoxO into the nucleus was detected. 
 
 
Figure 3-50: Ectopic expression and activation of dFoxO causes tracheal melanization. Melanization of the 
larval trachea resulted when dFoxO was ectopically expressed in the airways with the PPK4-Gal4 driver (A-B) 
and when activated in the terminal branches with the DRSF-Gal4 driver (C-D). Furthermore, a nuclear transloca-
tion of the transcription factor was observed. The panel in blue indicates DAPI staining of the nuclei. Merged 
image of GFP and DAPI. The scale bar is 100 µm. 
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3.11.2 Activation of dFoxO in the trachea has no impact on the fruit fly's viability 
Larvae ectopically expressing dFoxO within the trachea were able to form pupae and under-
went a complete metamorphosis, turning into the adult stage. Melanization remained to be 
visible during pupal and adult stage (Figure 3-51 A-C). 
 
 
Figure 3-51: Melanization of the trachea did not affect viability. Ectopic expression of dFoxO with the tra-
cheal specific PPK4-Gal4 driver resulted in tracheal melanization in larvae (A), pupae (B) and adults (C). It did 
not influence viability of the fly. 
 
Animals were able to rescue the effect of dFoxO activation and were able to form normal 





3.11.3 Activation of dFoxO in the respiratory system triggers phenol oxidase ac-
tivity required for melanin biosynthesis 
The key enzyme in the melanin biosynthetic pathway of the trachea is phenol oxidase (PO). 
To ensure that these blackish spots are really products of melanin and produced due to an in-
crease in PO activity, an ex vivo trachea assay using L-DOPA was performed. Dorsal tracheal 
trunks were dissected from wildtype w
1118
, PPK4-Gal4::UAS-dFoxO and PPK4-Gal4::UAS-
dFoxO-GFP larvae and presoaked in L-DOPA. Animals of PPK4-Gal4::UAS-dFoxO were 
used to exclude tracheal melanization resulting from influence of GFP. After one hour of in-
cubation, trachea from PPK4-Gal4::UAS-dFoxO and PPK4-Gal4::UAS-dFoxO-GFP, but not 
the control larvae, were strongly melanized, indicating a higher than normal level of PO activ-




Figure 3-52: Phenol oxidase activity assay. PO activity was assayed ex vivo using dissected larval trachea 
incubated in L-DOPA solution. Trachea from wild-type (wt) larva showed no detectable melanization (A), but 
trachea from PPK4-Gal4::UAS-dFoxO-GFP and PPK4-Gal4::UAS-dFoxO showed significant melanization, 
indicating a high level of PO activity (B-C). 
 
3.11.4 dFoxO - a possible regulator of tracheal melanization 
It was reported that the serine-protease inhibitor Spn77Ba is the regulator for tracheal 
melanization. Until now there is no information available how this serpin is getting controlled 
by upstream regulators. The dFoxO transcription factor, which is characterized by a distinct 
forkhead DNA-binding domain, is characterized as a central regulator of many target genes 
involved in metabolism, life span, cell cycle, growth, and stress resistance.  
In order to unravel, if dFoxO can function as a regulator of tracheal melanization and whether 
it could serve as a direct regulator of the serine protease inhibitor Spn77Ba, the promoter re-
gion of the serpin was examined in order to find potential binding sequences for dFoxO. 
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A putative binding site for dFoxO was found nearby the predicted promoter of Spn77Ba, at - 




Figure 3-53: Schematic representation of the putative promoter region and translational start of Spn77Ba. 
The predicted putative promoter of the serpin is shown in green. An 8 bp long dFoxO binding motif was found 
upstream to the promoter. An enhancer binding protein, CCAAT, was predicted by the transcription factor 
binding site analysis software. 
 
To confirm an in vitro binding of the dFoxO DNA-binding domain to this predicted dFoxO 
binding motif (Figure 3-54A), an electrophoretic mobility shift assays were performed. A 
clear shifting was visible (Figure 3-54 B).  
 
 A) 
  Cy5- GAAGTTTGTTGTTTATTGCACTTG  
  ||||||||||||||||||||||||  
  CTTCAAACAACAAATAACGTGAAC  
 
 B)        dFoxO FH DBD 
 
 
Figure 3-54: EMSA of dFoxO with the promoter of Spn77Ba. A) EMSA was applied in order to detect an in 
vitro binding of dFoxO DBD to a dFoxO binding motif within the Spn77Ba promoter. Approximately 250 ng of 
overexpressed and purified dFoxO protein was mixed with double stranded, labeled probe of the dFoxO binding 




4.1 Modeling of COPD in the airway epithelium of D. melanogaster 
The goal of this study was to unravel if Drosophila could be used as a COPD-model. This 
work presents one of the first reports for using D. melanogaster as a model organism to study 
the direct effects of cigarette smoke as the major risk factor for COPD. Mice, rat and guinea 
pigs serve as models of COPD. Nevertheless, some limitations of these models hinder the 
progress in our understanding of the pathogenesis, such as the complex interplay between the 
natural and adaptive immune responses, time consuming handling of transgenic mice to ob-
tain COPD-phenotypes and their genetic redundancy. Therefore, simple models such as the 
nematode C. elegans (Green et al, 2009) and especially the fruit fly Drosophila melanogaster 
are considered as new models, enabling very fast and broad insight of the physiological role 
and function of COPD-genes and their effects on the airways. In contrast to human epithelial 
cell culture, which has limitations, primarily those of any in vitro model, D. melanogaster, as 
an in vivo system, can be subjected as whole animal to cigarette smoke exposure. The current 
work highlights the advantages of the fruit fly Drosophila to model COPD-like phenotypes, 
over two other model organisms (Table 4-1). Although the fruit fly Drosophila has not been 
used previously as a smoking model for COPD research, it possess potential aspects for ana-
lyzing COPD-related target genes in the airway epithelium, except for those associated with 
the adaptive immune system. Moreover, the airways of the fruit fly share a comparable organ 
composition with striking similarities to vertebrates with respect to its physiology and reac-
tion towards pathogens and other biotic stimuli (Wagner et al, 2008). In contrast, the inverte-
brate C. elegans model lacks an respiratory system and can only absorb chemicals from CS by 
converting nicotine into cotinine (Green et al, 2009). 
Beside the remarkably decreased life span after exposure to cigarette smoke, D. melanogaster 
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4.1.1 Activation of the JAK-STAT pathway as an autocrine signaling after CSE? 
Until now very little is known about the early disease related response and other involved 
mechanisms caused by cigarette smoking. To unravel these mechanisms, the situation of ciga-
rette smoking in the airway epithelium of the fruit fly D. melanogaster was mimicked. 
Firstly, the current study has shown that the tracheal airway epithelium of 3rd instar larvae 
responds to cigarette smoke exposure. It was shown that activation of JAK-STAT signaling 
occurred at the posterior end of the dorsal branches of the airways as an early response to-
wards smoke, by utilizing the 10 x STATDGFP reporter. The higher expression at the dorsal 
branches indicates that the windpipe in human could be the first organ of the lung system to 
be affected and that JAK-STAT signaling is mediating its cytokine release and activation es-
pecially at this part. Turetz et al. also showed that different regions of the airways respond in 
different ways towards CSE. In their studies they have shown that the trachea epithelium is 
more sensitive to the stress of smoking than the small airways (Turetz et al, 2009). In this 
study, JAK-STAT signaling is one of the important signaling mechanisms in response to ciga-
rette smoke. In fact, recent studies have also demonstrated that JAK-STAT signaling is signif-
icantly increased in COPD patients (Chen et al, 2014; Ghosh et al, 2015; Yew-Booth et al, 
2015). Furthermore Victoni et al. also found an activation of JAK/STAT pathway by stimula-
tion of A549 epithelial cells after exposure to cigarette smoke (Victoni et al, 2014). Nicotine-
induced JAK2/ STAT3 activation in oral keratinocytes was investigated by Arredondo et al 
(Arredondo et al, 2006). 
Secondly, it was found that the exposure to cigarette smoke modulates gene expression of 
upd2 and upd3 but not that of upd, reflecting functional differences between these three cyto-
kines. However, ectopic expression of upd and upd3 in the trachea possess the same pheno-
type leading to thickening of the airway epithelium. The colocalized expression of upd2 and 
upd3 after CSE suggests that they take related roles in response to cigarette smoking, most 
likely by triggering an inflammatory-like response. Upd2 and upd3 can activate the 
transmembrane signal transducing receptor domeless thus generating active STAT92E. The 
overlapping expression pattern of the major JAK-STAT components upd2, upd3, the cytokine 
receptor domeless and the GFP expression of 10XSTAT92E-DGFP may indicate that JAK-
STAT signaling is getting activated as an early response towards cigarette smoke in the tra-
chea in an autocrine fashion (Figure 4-1). Moreover, the transcriptional activation of upd2 
and upd3 at 48 h CSE is higher than after 24 h CSE, which indicates that the activation de-
pends on the cigarette dosage. 
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The exact orthologs of the cytokines upd, upd2 and upd3 still remain unknown and their pres-
ence is still limited to the Drosophila genome as illustrated by Bayesian analysis. However, 
structural comparisons of upd3 to a known crystal structure of IL-6 demonstrate a similar pat-
tern of helices. Oldefest et al. has also described upd3 as an ancestor of the four-helix bundle 
cytokines (Oldefest et al, 2013). Detailed analyses were undertaken for IL-6 and its role in 
lung injury and inflammation induced by cigarette smoke in mice (Halappanavar et al, 2009).  
 
Figure 4-1: Activation of JAK-STAT signaling in Drosophila in comparison to human lung. JAK-STAT 
signaling was found to be one of the major signaling pathways in the fly's airways in response to cigarette 
smoke. The posterior ends of the dorsal branches were affected most probably in form of an autocrine cell 
signaling. Therefore our hypothetical model could be that upd2 and upd3 (as autocrine agents) are getting 
expressed, secreted and bound to the autocrine receptor domeless in the same affected region which finally leads 
to activation of JAK-STAT pathway in the trachea after CSE. In comparison to human lung it could be possible 
that JAK-STAT signaling is getting activated in the smokers windpipe (black line).  
 
Sustained activation of JAK-STAT signaling is causal to human cancers and its dysregulation 
has been linked to several tumors in Drosophila (Amoyel et al, 2014). For example frequent 
over activation of STAT3 and STAT5 promotes a variety of tumors and blood malignancies 
in human and hyper activation of HOP/ STAT92E pathway which results in melanonic or 
leukemia-like tumor formation in larvae and adult flies (Dearolf, 1998; Hanratty & Dearolf, 
1993). Activated nuclear STAT has been detected in many forms of chronic inflammation-
associated diseases, including lung cancer (Wu et al, 2014). This work has presented a de-
tailed molecular analysis of the upd-like ligands of the JAK-STAT pathway and has shown 
that upd2 and upd3 act in a similar fashion after CSE. Taken together, the observed expres-
sion of JAK-STAT signaling is indicative for the first response to cigarette smoke in the tra-
cheal epithelium and that its activation is restricted to the dorsal branches. 
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4.1.2 Role of redox-regulated transcription factors in the CSE-associated re-
sponses 
Injury of the epithelium by CSE smoke takes place due to enhanced expression of pro-
inflammatory mediators through redox-sensitive transcription factors e.g. nuclear NF-ҡB 
(Barnes & Karin, 1997; Di Stefano et al, 2002; Edwards et al, 2009). Innate immune pathways 
that converge on activation of NF-ҡB factors are of more central importance for various as-
pects of disease development and progression (Pantano et al, 2008).  
The activation of the fly's NF-ҡB ortholog relish was shown in cigarette smoke exposed Dro-
sophila larvae by nuclear translocation. This result demonstrates the physiological function 
and importance of the immune deficiency (IMD)-pathway (which is homologous to the TNF-
α pathway in human) as one signaling pathway involved in the response to cigarette smoke 
and disease. Works on guinea pigs have also shown an increased NF-ҡB nuclear binding after 
CSE in the airway epithelial cells and that it is associated with enhanced gene expression and 
protein release of pro-inflammatory cytokines (Nishikawa et al, 1999). Nishikawa et al. 
demonstrated an increased IL-8 gene expression and NF-kB activation in a guinea pig model 
after CSE. It is known that many inflammatory mediators present in COPD lungs can be in-
duced via the actions of NF-ҡB. Moreover, NF-ҡB is constitutively active in most tumors and 
chronic inflammatory conditions (Wu et al, 2014). In contrast, Rastrick et al. showed that NF- 
ҡB/IKK-2 does not play a prominent role in the inflammatory response to CSE and its im-
portance for COPD pathogenesis is only minor (Rastrick et al, 2013).  
 
FoxO3 is another transcription factor, which has been shown to modulate oxidative stress 
(Kops et al, 2002; Marinkovic et al, 2007). This study has shown that the Drosophila dFoxO 
is involved in the cigarette smoke regulated response via an induced translocation into the 
nucleus. The exact role of FoxO3 in cigarette smoke (CS)-induced lung inflammation and 
injury has not been studied yet. Thus, the pivotal role of dFoxO was examined under physio-
logical and CS conditions, using flies deficient in this transcription factor. Survival assays 
could not show that flies deficient in dFoxO possess an increased susceptibility when com-
pared to CSE wild type flies, like it was reported for CS-induced mice deficient in FOXO3 
(Hwang et al, 2011). Flies deficient in dFoxO show similar survival curves compared to wild 
type flies after CSE and it seems they were able to tolerate CSE slightly better. Airspace en-
largement or other structural changes within the airway epithelium of CS-exposed dFoxO 
deficient larvae were not detected, like it was reported for mice (Hwang et al, 2011). It is well 
known that variation in the FOXO3A gene is associated with longevity (Anselmi et al, 2009; 
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Flachsbart et al, 2009; Li et al, 2009; Pawlikowska et al, 2009; Soerensen et al, 2010; Willcox 
et al, 2008) and also plays a role in lung cancer (Herzog et al, 2009) (Mikse et al, 2010) (Yang 
& Hung, 2009). However, Däumer et al. found that smoking does not alter the FOXO3A as-
sociation with longevity (Daumer et al, 2014). 
 
Interestingly, this work identified the transcription factors relish and dFoxO as possible poten-
tial upstream regulators of the cytokine-like upd2 and upd3. Cigarette smoke mediated induc-
tion of upd2 and upd3 was significantly decreased in dFoxO- deficient flies. Furthermore, 
EMSA analysis underlines the potential up-stream regulatory role of dFoxO for upd2 and 
upd3 through its direct DNA-binding to conserved binding motifs within their promoters 
(Figure 4-2).  
 
promoter_Upd2 : CAATTAGTGTTTATGGCCTTG 
promoter_Upd3 : CATGTTTTGTTTATCTGCGAG 
 
 
Figure 4-2: Alignment of dFoxO binding motifs within the promoter regions of upd2 and upd3. Essential 
nucleotides of the conserved binding motifs for binding of dFoxO are in red color. 
 
However, qRT-PCR analysis has shown that in relish deficient flies, the transcript levels of 
upd2 and upd3 were also down-regulated, but not as strong as in dFoxO deficient animals. 
The fact that transcription of upd2 and upd3 was detected in relish deficient larvae, indicates 
that dFoxO is still functional in those animals. 
For upd no binding motifs, neither for relish nor dFoxO, were found within its promoter. This 
correlates with the observation that qRT-PCR analysis did not show any transcription of upd. 
Also there was no expression detected by X-Gal staining after CSE, indicating that upd is not 
taking part in the dFoxO-mediated response towards cigarette smoke. 
 
One way to activate dFoxO is via the JNK pathway, suggesting that this pathway may be ac-
tive after CSE. To unravel if the JNK-pathway is involved, a specific puckered reporter-Gal4 
line was mated to either LacZ-UAS or UAS-GFP (data not shown) (Adachi-Yamada, 2002). 
However, there was no detectable GFP expression or beta-galactosidase production in CS-
treated animals, which gives a first indication that JNK signaling is maybe not operative for 
activation of dFoxO in the smoke responsive manner. Also the utilization of a reporter system 
with AP-1 responsive TRE elements for monitoring JNK-activity (Chatterjee & Bohmann, 
2012) did not give any valuable signals. In future experiments it should be verified by qRT-
PCR that JNK pathway is not getting activated on CSE. 
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Another possible way for activation of dFoxO is via the the phosphatidylinositol 3-kinase/Akt 
pathway. It plays an important role in directly phosphorylating and inhibiting transcription 
factors of the forkhead family (Brunet et al, 1999; Kops et al, 1999). Therefore, a decreased 
phosphorylation of Akt and that of dFoxO could be possibly the reason for increased nuclear 
accumulation of dFoxO and its binding to upd2 and upd3. Kortylewski et al. also demonstrat-
ed a crosstalk of Akt signaling and IL-6 inducible JAK/STAT3 signal transduction 
(Kortylewski et al, 2003). The following figure shows the proposed pathways for upd2 and 
upd3 expression after CSE, based upon the findings of this work (Figure 4-3). 
 
Figure 4-3: Regulatory pathways for upd2 and upd3 expression after CSE. A nuclear translocation of 
dFoxO and relish was observed after CSE. Deficiency of relish and dFoxO TF (red crosses) had a negative effect 
on the transcription levels of upd2 and upd3. Animals deficient in dFoxO have shown a strong decrease in 
transcription levels of upd2 and upd3. A direct binding between the TF-dFoxO and the promoters of upd2 and 
upd3 was observed. There was no activation of the JNK-pathway after CSE. Therefore it is very likely that 
dFoxO activation happens through the insulin triggered IIS-pathway or a yet unknown mechanism.  
 
This is a new finding, which was not reported to date and it indicates that there is an existing 
crosstalk of dFoxO, JAK-STAT signaling and the IMD pathway in this cigarette smoke relat-
ed response. This finding could be also interesting for studies working with vertebrates, in 
exploring the role of IL-6 in vertebrate species (e.g. mice) and to check whether transcription 
factors like FoxO or NF-ҡB are also regulating them after CSE.  
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STAT is another redox-sensitive transcription factor that serves as a molecular switch be-
tween inflammation and cancer (Darnell et al, 1994; Grivennikov & Karin, 2010). It was re-
ported that STAT3 supports oncogenesis via binding to promoter regions of genes encoding 
inflammatory and cell cycle regulatory proteins (Yu et al, 2009; Zhong et al, 1994). In this 
study, translocation of STAT92E into the nucleus is most probably getting induced via activa-
tion of JAK-STAT signaling by binding of the extracellular ligands upd2 and upd3, whereas 
not by upd. In addition, there is increasing evidence that effective inhibitors of pro-
inflammatory chemokines and cytokines are beneficial for persons who have COPD 
(Proudfoot 2002; Lukacs et al. 2005) and that targeting of cytokines, e.g. IL-6 and several 
signal transduction pathways, including JAK-STAT and Ras has been proposed to inhibit the 
inflammatory pathways in COPD (Roxburgh & McMillan, 2015; Schleimer, 2005). 
 
Furthermore, this study has illustrated the activation of Nrf2 signaling in the fly's airways 
after CSE. Although the transcription factor Nrf2 was shown to be involved in preventing 
cigarette smoke- dependent lung disease (Kelsen et al, 2008), no direct evidence has been 
shown that smoke of cigarette is sensed by the Nrf2 activation and till now the data is partly 
inconsistent (Brigelius-Flohe et al, 2012; Muller & Hengstermann, 2012). This work demon-
strates that the Drosophila's ortholog cncC (cap'n'collar) is involved in the response to oxida-
tive stress of smoke as shown by GFP accumulation inside the nucleus. Thus, Nrf2/cncC is 
getting activated after exposure to CS and is therefore important for further transcriptional 
control of its target genes. Further, fly lines carrying Nrf2-inducible ARE elements were test-
ed. However, no reproducible GFP signals were detected after CSE (Chatterjee & Bohmann, 
2012). Still it is unclear whether the problem has to do with the reporter fly line and therefore 
qRT PCR experiments could be applied to address this issue in future and to confirm tran-
script levels of Nrf2/ cncC after CSE. 
The GstD1 gene encodes a glutathione-S-transferase which was found to be expressed in re-
sponse to cigarette smoke as demonstrated by the Gst-D-GFP reporter line. GstD. It is im-
portant for the detoxification of xenobiotics and normally activated via the Keap1/Nrf2 sig-
naling pathway (Ma, 2013; Sykiotis & Bohmann, 2008). Gst is induced in Drosophila during 
normal aging and when the flies are challenged with oxidative stress, fluctuations in redox 
state and electrophilic xenobiotics (Landis et al, 2004; Sykiotis & Bohmann, 2008; Zou et al, 
2000). The Gst-D1 promoter region contains consensus-binding motifs for Nrf2 and dFoxO 
(Landis et al, 2012). In upcoming works it would be interesting to investigate, if Gst-D ex-
pression is exclusively mediated by Nrf2/ cncC, dFoxO or both. 
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4.1.3 Airway remodeling as a response to CSE 
Chronic obstructive pulmonary disease (COPD) is characterized by extensive thickening of 
the airway epithelium leading into progressive and poorly reversible airflow limitation and 
airway distensibility (Jeffery, 2004; Postma & Timens, 2006).  
Interestingly, this phenomenon of a physiologic abnormality of the airway epithelium was 
observed in smoke exposed animals. The epithelial layer of cigarette smoke exposed trachea 
was significantly thicker than in control animals. However, little is known, if thickening has a 
negative impact on lung function, by increasing airflow limitation or if it may serve as a pro-
tective mechanism by increasing the stiffening of the airway wall to attenuate the sporadic 
broncho constriction (Holgate et al, 2000; Holgate et al, 2003; Holgate et al, 2004; Pare et al, 
1997; Wang et al, 2003; Ward et al, 2001). This work unraveled JAK-STAT signaling in re-
sponse to cigarette smoke as an important pathway that may play a role in the pathogenesis of 
COPD. Several findings provide evidence that an altered airway structure has negative effects 
rather than playing a protective role. This study demonstrated that ectopic expression of the 
members of JAK-STAT signaling results into structural remodeling.  
Ectopic expression of upd, upd3 or hopscotch caused epithelial hyperplasia and metaplasia in 
the airways and ectopic expression of the constitutive active form of domeless affected nega-
tively on the cell size of the epithelial cells.  
It was also shown in mouse lung that over expression of two closely related cytokines inter-
leukin-6 (IL-6) and 11 leads into thickening of airway walls and sub-epithelial airway fibrosis 
(Kuhn et al, 2000). Works of Ochoa et al. describes that IL-6 promotes lung carcinogenesis 
and histopathologic analysis of IL-6 KO mice revealed less extensive lesions of hyperplasia 
(Ochoa et al, 2011). This is the first study demonstrating airway remodeling in Drosophila 
initiated by CSE and that the injured cells release cytokines at the site of injury, which could 
be the cause for thickening after their activation. Thus, for future works it would be of high 
interest to find out, if epithelial thickening occurs in upd-deficient animals after application of 
CSE. 
 
4.1.4 A possible dFoxO- mediated signaling cascade 
Molecular as well as functional analyses of possible candidate genes helped in gaining insight 
of the underlying CSE-mediated mechanisms. A possible signaling cascade mediated by 
dFoxO is presented in Figure 4-4. Taken these results under consideration one can draw the 
following model: CSE serves as an inflammatory stressor which leads into activation of JAK-
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STAT signaling in the airways. A yet unknown upstream regulator or signaling pathway is 
expressing and activating the transcription factor dFoxO. DFoxO then directly binds to 
conserved dFoxO-binding motifs within the promoters of upd2 and upd3 as shown by 
Bandshift-analysis. Thus, JAK-STAT activation by CSE is mediated by local upd2 and upd3 
expression whereas not by upd.  
This high up-regulation of these cytokines may result in a strong and fast activation of JAK-
STAT signaling and an abnormal stress response. This could be the cause for airway 
remodeling in the form of hyperplasia. It resembles pathotypes seen in COPD patients. More-
over, these results indicate a new crosstalk of JAK-STAT signaling and the transcription fac-
tor dFoxO, which may be operative for CSE induced structural changes in the trachea. 
 
 
Figure 4-4: Proposed dFoxO dependent activation of JAK-STAT signaling after CSE. CSE activates JAK-
STAT signaling in the airway system of the fly. dFoxO binds to conserved dFoxO binding motifs within the 
promoters of upd2 and upd3. JAK-STAT activation is mediated by local upd2 and upd3 expression, but not by 




4.2 Utilization of bPAC to study cAMP signaling in the airways of D. 
melanogaster 
Current findings of this work show novel effects of cAMP signaling and thus contribute to a 
better understanding of airway diseases. Up to date only little is known about how alterations 
and higher intracellular cAMP levels effect the respiratory system (Billington & Hall, 2012). 
Normally, an increase in intracellular cAMP reduces smooth muscle tone, thus dilating the 
airways. Moreover, it plays a key role in the functions of many airway cells including control-
ling ciliary beat frequency (critical for mucus clearance) (Salathe, 2002) and suppressing the 
pro-inflammatory activity of various immune and inflammatory cells. However, it is arguably 
the inhibitory effect of increased cytosolic cAMP levels on the contraction of ASM cells 
(Billington et al, 2013). It has been reported that cAMP leads to up-regulation and release of 
cytokines and chemokines such as IL-6, IL-8, and GM-CSF (Ammit et al, 2000; Lazzeri et al, 
2001; Pang & Knox, 2000). Thus cAMP can have both, pro- and anti-inflammatory effects on 
ASM cell function. 
It has been shown that cAMP dependent effectors like protein kinase A (PKA) negatively 
regulate serum response factor (SRF) activity, a crucial transcription factor impacting smooth 
muscle cell differentiation including that of ASM cells (Davis et al, 2003; Liu et al, 2003a; 
Miano et al, 2007). Similar effects were shown for the vascular smooth muscle cells that PKA 
negatively regulates SRF and inhibits differentiation (Blaker et al, 2009; Davis et al, 2003). 
The Drosophila serum response factor (DSRF) homolog is expressed in the precursor cells of 
terminal trachea. This work has shown that high levels of cAMP activity may have negative 
impact on the expression of the blistered/DSRF gene in the airway system, which in turn re-
sults in this impaired branching of the terminal branches. Thus, the current study shows that 
cAMP might be an important second messenger for terminal branching.  
Triggering such high concentrations of cAMP within the respiratory system created a tissue-
degrading phenotype. This destruction of terminal branching in the airways of the fly 
resembles the pathotype seen in human during COPD pathogenesis. This finding also 
demonstrates that the right dose of medication, e.g. asthma inhalers for asthma and COPD 
patients, is very crucial. Kume et al. highlighted this disparity by quantifying both airway 
relaxation and cAMP production of tracheal strips of horses in response either to forskolin (a 
direct activator of AC) or to isoprenaline (a non-selective β-adrenoceptor agonist) (Kume et 
al, 1994). Both agents were able to induce airway relaxation but interestingly forskolin 
induced twice as much cAMP production as isoprenaline. This emphasizes the importance of 
a fine tuned regulation of this second messenger within the airways. 
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In this work, a high cAMP production by blue-light induced bPAC is above the basal norm 
concentrations leading into defects of tracheal branching. Possibly it affected the expression 
and activity of DSRF via activation of PKA in the terminal branches. This result is similar to 
the finding of Mattila et al., where the authors describe dFoxO to regulate the expression of 
another AC, the AC76E, which also regulates cAMP-levels. The expression of AC76E had a 
remarkable effect on pupa formation, size (limits growth) and stress resistance (Mattila et al, 
2009), similarly like it was observed after bPAC activation. These results show that in 
Drosophila ACs play a role in regulation of growth of several tissues.  
Further I have demonstrated that blue-light activation of bPAC resulted into translocation of 
dFoxO into the nucleus. Additionally, higher cAMP levels had an impact on tracheal 
melanization. Thereby it could be possible that the translocated dFoxO functioned as an 
initiator for this melanization cascade by binding to a dFoxO binding motif within Spn77Ba, 
leading to inhibition of this serpin and thus starting melanin biosynthesis. A proposed 
regulation cascade is shown in Figure 4-5. 
 
Figure 4-5: Proposed model of cAMP- dependent inhibited differentiation of the terminal branches. 
Activation of bPAC in the respiratory system of the fly increases cAMP levels and cAMP dependent effectors 
like protein kinase A (PKA) which may negatively regulate DSRF and the TF cut, leading to inhibited 
branching. Tracheal melanization could be possible via the cAMP/dFoxO pathway. Moreover, activation of 
cAMP/PKA by bPAC may lead to activation of calcium channels releasing Ca
2+
 into the cytoplasm.  
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It could be possible that an activation of such high cAMP levels could lead to parallel activa-
tion of Ca
2+
-signaling via PKA in the airway epithelium of the fly. Kamp et al. has shown a 
regulation of calcium channels through the cAMP/PKA pathway (Kamp & Hell, 2000). Dixon 
et al. addressed that an elevation of free intracellular Ca
2+
 via L-type voltage-gated calcium 
channels is associated with contracted and tightened ASM cells (Dixon & Santana, 2013).  
It was observed for few animals that expression and activation of the DREADD receptor 
M1D1 (for increasing Ca
2+
 in the airway epithelium), resulted into a similar phenotype seen in 
animals expressing bPAC. The epithelial cells of the trachea were compressed and their cell 
number got increased (Appendix 7.7, Figure 7-10). 
 
 
4.3 Limitations and challenges using the fruit fly as COPD-model 
While many previous studies have used D. melanogaster to study the innate immune response 
(Pandey & Nichols, 2011), this one of the initial studies to expose D. melanogaster to CS. 
The fruit fly has provided valuable insight about cigarette smoke- induced altered host de-
fense mechanisms of the airways on molecular as well as on structural level. The experi-
mental approach to model COPD within the fruit fly's airways was by direct inhalative chal-
lenge to CSE (Cohen & George, 2013). However, COPD pathology occurs normally after a 
long period of heavy smoking, thus exposure of cigarette smoke on 3rd instar larvae does not 
replicate the entire complexity of this disease and can only give an insight of early disease 
development leading to COPD (Petty & Rennard, 2000). Interestingly, major features of 
COPD we were able to model within the respiratory tract of the fly (Table 4-2). Nevertheless, 
cigarette smoke had only less impact on the morphology of the terminal branches. The miss-
ing emphysema development, in form of terminal cell destructions or other alterations, could 
be explained by the short duration of exposure of the larvae (Leberl et al, 2013). Another limi-
tation is the missing mucus hyper secretion in the larvae's trachea. Airway secretory cells such 
as clara cells and goblet cells, which are important for mucus production in the human lung 








Table 4-2: COPD-features in the airways of D. melanogaster after CSE 
COPD-Feature  
Airway remodeling in form of a thickened epithelial layer + 
Highly up-regulation of JAK-STAT signaling  + 
Oxidative stress, indicative by redox-sensitive transcription factors + 
Reduced lifespan + 
Emphysema (small airways narrowing) - (?) 
Mucus production (sputum) - 
Cough / squeezing - 
 
However, the current challenge in COPD research is to identify molecular mechanisms that 
are involved in this pathophysiology. These understanding will help to unravel the effects of 
smoking and assist to the development of new treatments. 
This study could unravel important signaling pathways and key enzymes after CSE in the 
fruitfly, which were reported to mediate acute cigarette smoke-induced inflammation in hu-
man. Therefore D. melanogaster offers a novel model to exclusively investigate the role of 





The results of this current work suggest that the model organism D. melanogaster offers a 
novel in vivo approach to specifically study innate immune deficiencies resulting from expo-
sure to cigarette smoke. This study paves paths for the establishments of D. melanogaster as a 
model for basic COPD research with developments on various CSE models using 3rd instar 
larvae of D. melanogaster. This work investigated the in vivo impact of CSE, primarily in the 
tracheal epithelium. After CSE the examination of expression patterns of upd ligands revealed 
a differential patterning. The induction of upd2 and upd3 transcripts was significantly up-
regulated in wildtype but strongly reduced in dFoxO deficient flies. This work depicts that 
cigarette smoke leads to structural remodeling including thickening of the epithelial layer in 
parallel with activation of JAK/STAT signaling, potentially mediated by dFoxO. Thus, these 
findings provide a novel crosstalk of JAK-STAT signaling and dFoxO in the trachea.  
Finally, this work also illustrates an induced destruction of the terminal airway structure after 
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7.1 Activation of Wnt signaling after CSE 
 
Figure 7-1: Activation of Wnt signaling in the respiratory track of D. melanogaster after CSE. The 
inidicator fly line for Wnt-pathway activity, which expresses a RFP under the native promotor of frizzled 3, was 
investigated under physiological conditions (A and C) and after CSE (B and D). Wnt signaling got expressed in 


















Figure 7-2: Neighbor joining analysis of upd upd2 and upd3 genes of Drosophila species. Upd, upd2 and 
upd3 are Drosophila species specific genes as depicted by NJ. However, NJ method could not extract that upd3 




















Table 7-1: List of upd, upd2 and upd3 genes 







































































7.4 Expression levels of upd2 and upd3 after hypoxia 
 
 
Figure 7-4: Relative expression of upd2 and upd3 in the trachea after treatment with hypoxia. Upd2 tran-
script levels were significantly increased in the trachea after hypoxia (3% O2, 1 h). Whereas, only a slight in-
crease of upd3 was observed for hypoxia treated animals. Upd transcripts remained unchanged in tracheas of 
animals with and without hypoxia treatment (data not shown). Values are means of at least 3 independent exper-
iments ± SEM. Y-axis is expressed as the fold change and significances are calculated using t-test with **p = 
0.01 to 0.001, ***p < 0.001, NS p > 0.05. 
 
7.5 Cloning of dFoxO DBD into pET28a (+) 
 
pEX-A2 dFoxO DBD 
 
     A)             M           1                         B)      M          2 











Figure 7-5: Double digest of pEX-A2 dFoxO DBD with NheI and HindIII and gel-purified dFoxO DBD. 
The plasmid pEX-A2 dFoxO DBD containing the synthetic gene coding for the dFoxo DNA binding domain 
was transformed into E.coli DH5α. The purified plasmid DNA of pEX-A2 dFoxO DBD (2450 bp) was restricted 
with NheI and HindIII and yielded into 2 fragments: a part of unrestricted plasmid DNA pEX-A2 dFoxO DBD 

















        M     G      S      S      H     H      H      H     H     H      S      S     G  … 
                                                                       NheI 
CTGGTGCCGGCGGGCAGCCATATGGCTAGCAATGCGAATGCAGCCAAGAAGAAC     
L         V     P      R      G      S      H     M     A     S      N     A      N      A     A     K      K     N .. 
                                                                       HindIII 
 N-terminus…GGCAGGGCCTAGAAGCTT 
                G     R      A       
 
Figure 7-6: Cloning scheme of dFoxO DBD into pET28a (+). The start methionine is highlighted in a frame, 
the HIS-tag in red and the STOP codon in green color. 
 
 
Vector map of pET28a (+) FoxO_DBD 
 
 
Figure 7-7: Vector pET28a (+). The pET28a (+) vector contains kanamycin resistance. Unique sites are shown 
on the map. The cloning/expression region of the coding strand transcribed by T7 RNA polymerase is shown. 
The pET28a (+)dFoxO DBD vector was constructed by cloning the dFoxO DBD codon sequence into the vec-
tor’s multiple cloning site, using NheI and HindIII restriction sites. This cloning strategy allows N-terminal His-




Sequencing result of pET28a (+) FoxO_DBD  
                                                                       
dFoxO_DBD_seq   1 : AATTTNGNTTAACTTTAAGAAGGAGATATACCATGGGCAGCAGCCATCAT 
dFoxO_DBD       - : -------------------------------------------------- 
                                                                       
dFoxO_DBD_seq  51 : CATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGCTAG 
dFoxO_DBD       1 : ---------------------------------------------GCTAG 
                                                                       
dFoxO_DBD_seq 101 : CAATGCGAATGCAGCCAAGAAGAACTCATCGCGTCGCAATGCATGGGGAA 
dFoxO_DBD       5 : CAATGCGAATGCAGCCAAGAAGAACTCATCGCGTCGCAATGCATGGGGAA 
                                                                       
dFoxO_DBD_seq 151 : ATCTATCCTATGCGGATCTCATCACGCATGCCATTGGATCGGCCACCGAC 
dFoxO_DBD      55 : ATCTATCCTATGCGGATCTCATCACGCATGCCATTGGATCGGCCACCGAC 
                                                                       
dFoxO_DBD_seq 201 : AAACGATTGACACTGAGTCAGATTTACGAGTGGATGGTCCAGAATGTGCC 
dFoxO_DBD     105 : AAACGATTGACACTGAGTCAGATTTACGAGTGGATGGTCCAGAATGTGCC 
                                                                       
dFoxO_DBD_seq 251 : ATATTTCAAGGACAAGGGCGATTCGAATAGCAGTGCCGGATGGAAGAACT 
dFoxO_DBD     155 : ATATTTCAAGGACAAGGGCGATTCGAATAGCAGTGCCGGATGGAAGAACT 
                                                                       
dFoxO_DBD_seq 301 : CCATACGTCACAATCTGTCGCTGCACAACCGCTTTATGAGGGTCCAAAAC 
dFoxO_DBD     205 : CCATACGTCACAATCTGTCGCTGCACAACCGCTTTATGAGGGTCCAAAAC 
                                                                       
dFoxO_DBD_seq 351 : GAGGGCACCGGCAAGTCATCCTGGTGGATGCTCAACCCGGAGGCCAAGCC 
dFoxO_DBD     255 : GAGGGCACCGGCAAGTCATCCTGGTGGATGCTCAACCCGGAGGCCAAGCC 
                                                                       
dFoxO_DBD_seq 401 : CGGCAAGTCTGTGCGCCGCCGTGCCGCTTCCATGGAGACGTCCCGGTACG 
dFoxO_DBD     305 : CGGCAAGTCTGTGCGCCGCCGTGCCGCTTCCATGGAGACGTCCCGGTACG 
                                            
dFoxO_DBD_seq 451 : AGAAGCGGCGCGGCAGGGCCTAG 
dFoxO_DBD     355 : AGAAGCGGCGCGGCAGGGCCTAG 
                                            
 
Figure 7-8: Alignment of sequenced pET28a (+) FoxO_DBD and original dFoxO DBD sequence. The se-
quencing result obtained from https://www.gatc-biotech.com/en/index.html confirms the correct insertion of 
dFoxO DBD into pET28a (+) vector. The start methionine is highlighted in a frame, the HIS-tag in red and the 
STOP codon in green color. 
 






Figure 7-9: Remodeling of the terminal cells after CSE. The terminal branches of CS-exposed 3rd instar lar-
vae looking curlier (B) in comparison to control animals (A). In green: α-WKD antibody, scale bar is 100 µm. 
 
7.7 Application of DREADD for targeted manipulation of the tra-
chea 
 
Figure 7-10: CNO-activation of DREADD (M1D1) receptor in the respiratory tract of the fly. The 
DREADD receptor (M1D1) was activated in vivo in the trachea using PPK4-Gal4 and by feeding animals CNO. 
Activation of DREADD, leads into decreased cell size as visualized by DAPI (blue) and α-coracle staining (red) 
(B and D) in comparison to control animals (A and C). Scale bar: 100 µm, crosses were performed using UAS-
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